{"gene":"P2RX4","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":1998,"finding":"P2X4 and P2X6 subunits co-assemble into heteromeric ATP-gated channels with a novel pharmacological phenotype (sensitive to alpha,beta-methylene ATP, blocked by suramin and Reactive Blue 2), distinct from homomeric P2X4; assembly shown by co-purification from HEK-293 cells with epitope-tagged constructs and functional characterization in Xenopus oocytes.","method":"Co-purification/pulldown from HEK-293 cells with epitope-tagged subunits; two-electrode voltage-clamp in Xenopus oocytes","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — biochemical co-purification combined with functional electrophysiology in heterologous expression system, demonstrating novel pharmacological phenotype","pmids":["9736638"],"is_preprint":false},{"year":2002,"finding":"P2X4 receptor is N-linked glycosylated; only the glycosylated 58-kDa form is expressed on the cell surface (non-glycosylated 44-kDa form is detergent-insoluble and intracellular), establishing that N-linked glycosylation is required for plasma membrane localization and detergent solubility. P2X4 mediates the positive inotropic effect of ATP in cardiac myocytes.","method":"Tunicamycin treatment to block glycosylation; cell-surface biotinylation with streptavidin pulldown; antisense oligonucleotide knockdown; 45Ca influx assay; contractile amplitude measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal methods (glycosylation inhibition, surface biotinylation, antisense KD, calcium influx, contractility) in a single study","pmids":["11864978"],"is_preprint":false},{"year":2005,"finding":"P2X1 and P2X4 subunits form heteromeric trimeric receptors; co-purification with hexahistidyl-tagged P2X1 and BN-PAGE confirmed trimeric complexes containing both subunits. Heteromeric P2X1+4 receptors have kinetics resembling homomeric P2X4 but pharmacology (alpha,beta-methylene ATP sensitivity, suramin/TNP-ATP antagonism) resembling homomeric P2X1.","method":"Affinity co-purification with His-tagged P2X1; BN-PAGE; two-electrode voltage-clamp in Xenopus oocytes","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — biochemical co-purification with size confirmation by BN-PAGE plus functional electrophysiology","pmids":["15686495"],"is_preprint":false},{"year":2007,"finding":"P2X4 receptor is required for ATP-induced microglial chemotaxis; pharmacological blockade and lentiviral shRNA knockdown of P2X4R both significantly suppressed microglial chemotaxis. P2X4R affects the PI3K/Akt pathway downstream of P2Y12R by contributing calcium influx, since chelating extracellular calcium reduced Akt phosphorylation.","method":"Dunn chemotaxis chamber; PI3K inhibitors (wortmannin, LY294002); Akt phosphorylation assay; lentiviral shRNA knockdown; various P2X4R antagonists","journal":"Glia","confidence":"High","confidence_rationale":"Tier 2 / Strong — pharmacological blockade with multiple antagonists corroborated by RNAi knockdown, with mechanistic pathway (PI3K/Akt) established","pmids":["17299767"],"is_preprint":false},{"year":2007,"finding":"P2X4 and P2X7 physically associate to form heteromeric receptors: co-immunoprecipitated from HEK293 cells and from bone marrow-derived macrophages. P2X7 increases cell-surface fraction of P2X4 two-fold. A dominant-negative P2X4 mutant (C353W) inhibits P2X7-mediated currents >2-fold, and P2X4S341W co-expressed with P2X7 confers ivermectin potentiation and TNP-ATP sensitivity absent from P2X7 alone.","method":"Co-immunoprecipitation from HEK293 cells and macrophages; cell-surface biotinylation; dominant-negative mutagenesis; whole-cell patch clamp","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reciprocal Co-IP from native cells plus mutagenesis plus electrophysiology, multiple orthogonal methods","pmids":["17785580"],"is_preprint":false},{"year":2009,"finding":"P2X4 receptors are predominantly in intracellular lysosomal compartments in alveolar macrophages; phagocytosis of zymosan or chloroquine-induced lysosomal secretion rapidly (within 4 h) increases functional surface P2X4R expression 2–7-fold without changing total protein, while classical activation (IFN-γ/TNF-α or IFN-γ/LPS) reduces surface and functional P2X4R 3-fold without altering total protein.","method":"Western blot; cell-surface biotinylation assay; whole-cell patch clamp; chloroquine treatment; phagocytosis stimulation","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (biotinylation, electrophysiology, pharmacological stimuli) demonstrating lysosomal trafficking mechanism","pmids":["19283779"],"is_preprint":false},{"year":2012,"finding":"CCL2/CCR2 signaling promotes trafficking of P2X4R from lysosomal compartments to the cell surface of microglia via lysosomal exocytosis, increasing surface P2X4R without changing total cellular expression; this enhances ATP-induced Akt phosphorylation (a P2X4R-mediated response).","method":"Quantitative cell-surface biotinylation assay; time-lapse imaging of GFP-tagged P2X4R; lysosomal enzyme (β-hexosaminidase) release assay; Akt phosphorylation assay; CCR2 antagonist","journal":"Purinergic signalling","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches (biotinylation, live imaging, lysosomal exocytosis assay, signaling readout) in a single study","pmids":["22222817"],"is_preprint":false},{"year":2012,"finding":"Prolonged ATP activation of native P2X4 channels in microglia induces non-cytolytic pore dilation permeable to NMDG+ and large fluorescent dyes; this is independent of pannexin hemichannels (insensitive to carbenoxolone) and is inhibited by wortmannin (PI kinase inhibitor), indicating regulation by phosphoinositide levels.","method":"Electrophysiology (patch clamp); dye uptake assay; carbenoxolone blockade; wortmannin treatment in BV-2 and primary murine microglia","journal":"Glia","confidence":"High","confidence_rationale":"Tier 2 / Strong — electrophysiology with pharmacological dissection distinguishing P2X4 from P2X7 pore-dilation mechanisms, multiple inhibitors","pmids":["22318986"],"is_preprint":false},{"year":2012,"finding":"P2X4 receptor lateral mobility in microglial processes is regulated by ATP-induced calcium influx and the p38 MAPK pathway; ATP activation increases receptor mobility, and p38 MAPK selectively regulates the slowly mobile receptor population in activated microglia.","method":"Single-molecule imaging with quantum dot-labeled P2X4 receptors; calcium chelation; p38 MAPK inhibitors; resting vs. LPS-activated microglia","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single-molecule imaging with pharmacological inhibitors, single lab","pmids":["22393055"],"is_preprint":false},{"year":2014,"finding":"P2X4 receptor is predominantly localized to lysosomes and is targeted there by tyrosine-based and di-leucine-like trafficking motifs in its C-terminal and N-terminal regions, respectively; pHluorin imaging showed cell surface and intracellular fractions are cell-type and compartment-specific, and ivermectin does not increase the PM fraction of P2X4 but acts allosterically.","method":"pH-sensitive fluorescent P2X4-pHluorin constructs; live-cell imaging in HEK-293, hippocampal neurons, C8-B4 microglia, ATII cells; ivermectin treatment","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — purpose-built optical probe validated against WT P2X4 with multiple cell types and functional validation of allosteric mechanism","pmids":["24935743"],"is_preprint":false},{"year":2014,"finding":"P2X4 receptor activity-dependently inhibits TRPM6 Mg2+ channel activity; a P2X4 mutant with altered ATP sensitivity failed to inhibit TRPM6, and P2X4 did not inhibit the close homologue TRPM7, demonstrating specificity. Standard kinase inhibitors (PKC, PKA, PI3K) did not prevent this inhibition.","method":"Whole-cell patch clamp; P2X4 ATP-sensitivity mutant; P2X6 (non-functional) control; kinase inhibitor panel","journal":"Pflugers Archiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electrophysiology with mutagenesis and specificity controls, single lab","pmids":["24413910"],"is_preprint":false},{"year":2015,"finding":"Endolysosomal P2X4 Ca2+ release is required for endolysosomal membrane fusion; P2X4 and calmodulin (CaM) form a complex at endolysosomal membranes, and P2X4 activation recruits CaM to promote fusion and vacuolation in a Ca2+-dependent manner. CaM inhibition suppressed P2X4-triggered fusion and vacuolation.","method":"P2X4 overexpression and dominant-negative mutant; cell-free endolysosome fusion assay; vacuole enlargement assay; co-immunoprecipitation of P2X4–CaM complex; CaM inhibitors; P2X4 gene disruption","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — cell-free reconstitution of fusion, co-IP of P2X4–CaM complex, dominant-negative and gene disruption, multiple orthogonal methods","pmids":["26101220"],"is_preprint":false},{"year":2015,"finding":"P2X4 channels act as mechanotransducers in podocytes via an indirect mechanism: mechanical stimulation triggers ATP release from podocytes, which then activates P2X4 channels (TRPC6-independent), leading to increased intracellular Ca2+ and actin cytoskeleton reorganization. Mechanically induced currents were significantly decreased by P2X4 blocker 5-BDBD and were insensitive to TRPC1/3/6 knockout or broad TRPC blocker.","method":"Patch clamp of podocytes; genetic inactivation of TRPC6, TRPC1/3/6; 5-BDBD pharmacological blockade; fluorometric ATP release assay; actin cytoskeleton imaging","journal":"Journal of the American Society of Nephrology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockouts plus pharmacology plus ATP release measurement plus cytoskeletal readout, multiple orthogonal methods","pmids":["26160898"],"is_preprint":false},{"year":2015,"finding":"BX430 is a selective, non-competitive allosteric antagonist of human P2X4 with submicromolar potency (IC50 = 0.54 µM); concentration-response curves show insurmountable blockade consistent with a non-competitive allosteric mechanism. BX430 suppresses both ATP-evoked currents and ivermectin-potentiated membrane permeabilization/pore dilation.","method":"Calcium uptake assay; patch-clamp electrophysiology; fluorescent dye uptake (pore dilation); single-cell calcium imaging in THP-1–derived macrophages","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple assays (electrophysiology, calcium imaging, dye uptake) establishing allosteric mechanism with selectivity profiling across all P2X subtypes","pmids":["25597706"],"is_preprint":false},{"year":2015,"finding":"P2X7 C-terminus interacts with P2X4, and this interaction is driven by ATP; disruption of P2X4 by knockout attenuated P2X7-induced cell death, dye uptake, and IL-1β release in macrophages.","method":"Co-immunoprecipitation; FRET experiments; P2X4 knockout macrophages; functional assays (cell death, dye uptake, IL-1β ELISA)","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus FRET plus KO functional readouts, single lab","pmids":["26456657"],"is_preprint":false},{"year":2016,"finding":"In the hypothalamic arcuate nucleus, P2X4 receptors are expressed presynaptically on AgRP-NPY neuron terminals (not on somata) and mediate ATP-facilitated GABA release onto POMC and paraventricular nucleus neurons; presynaptic P2X4 expression and responses are decreased by food deprivation and partially restored by leptin.","method":"BAC transgenic tdTomato reporter mice; immunohistochemistry with cell-specific GFP reporter lines; whole-cell electrophysiology in brain slices; food deprivation and leptin treatment","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — purpose-built reporter mouse crossed with cell-specific lines, combined with direct electrophysiology demonstrating presynaptic functional P2X4 activity","pmids":["27559172"],"is_preprint":false},{"year":2017,"finding":"FRET analysis confirms that P2X4 and P2X7 subunits can physically interact (significant FRET signals detected between fluorophore-labeled subunits in Xenopus oocytes); however, functional electrophysiological analysis of coexpressed human P2X4 and P2X7 is consistent with independent homomers only—no novel electrophysiological phenotype attributable to heteromers was detected.","method":"FRET with EGFP/TagRFP-labeled subunits in Xenopus oocytes; two-electrode voltage clamp; selective pharmacological inhibitors","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FRET confirms proximity but functional data argues against a dominant heteromeric phenotype; single lab","pmids":["29213241"],"is_preprint":false},{"year":2018,"finding":"SDF-1α triggers mitochondrial ATP production, pannexin-1-dependent ATP release, and localized co-accumulation of mitochondria with P2X4 receptors at the leading edge of T cells; autocrine P2X4 stimulation drives Ca2+ influx and sustains mitochondrial ATP synthesis required for pseudopod protrusion, T cell polarization, and migration. P2X4R antagonism blocked T cell activation and migration in vitro and prevented allograft rejection in a mouse lung transplant model.","method":"Live-cell imaging of mitochondria and P2X4 co-localization; Ca2+ imaging; P2X4 inhibition; pannexin-1 blockade; in vitro migration assays; mouse lung transplant model with P2X4 antagonist treatment","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct localization experiment tied to functional consequence (pseudopod/migration), confirmed in vivo in transplant model, multiple orthogonal methods","pmids":["29894310"],"is_preprint":false},{"year":2018,"finding":"P2RX4 expressed in sensory neurons co-localizes with BDNF and controls Ca2+ influx in DRG neurons; in P2RX4-deficient mice, BDNF-dependent signaling in the dorsal horn (Erk1/2 phosphorylation, GluN1 phosphorylation, KCC2 downregulation) triggered by peripheral inflammation is impaired, placing P2RX4 upstream of neuronal BDNF release during inflammatory pain.","method":"P2RX4 knockout mice; immunofluorescence co-localization; Ca2+ imaging in DRG neurons; western blot for phospho-Erk1/2, phospho-GluN1, KCC2 in spinal cord","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with multiple molecular pathway readouts establishing P2X4→BDNF→spinal sensitization pathway","pmids":["29343707"],"is_preprint":false},{"year":2018,"finding":"P2X4R regulates calcium entry and lysosomal exocytosis in hepatic myofibroblasts (hMFs); P2X4 genetic invalidation or pharmacological inhibition blunted hMF activation marker expression and fibrogenic properties and impacted ATP release and profibrogenic secretory profile, placing lysosomal P2X4-mediated calcium and exocytosis upstream of transcription factor activation in liver fibrogenesis.","method":"P2X4 KO mice; bile duct ligation and MCD diet models; P2X4 siRNA and pharmacological inhibition; calcium entry assays; lysosomal exocytosis measurement; hMF isolation from mouse and human liver","journal":"Journal of hepatology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO in two in vivo fibrosis models, human cell validation, siRNA, and calcium/exocytosis mechanistic readouts","pmids":["29802948"],"is_preprint":false},{"year":2020,"finding":"Bone marrow plasma cells use P2RX4 to sense extracellular ATP released by osteoblasts through PANX3; P2RX4 promotes plasma cell survival by regulating endoplasmic reticulum homeostasis—P2RX4 blockade causes accumulation of ER stress-associated proteins ATF4 and CHOP, and B-lineage deletion of the pro-apoptotic ATF4 target Chop prevents bone marrow plasma cell death on P2RX4 inhibition.","method":"P2rx4 and Panx3 knockout mice; in vitro osteoblast-plasma cell co-culture; 5-BDBD P2RX4-specific inhibitor; western blot for ATF4, CHOP; B-lineage-specific Chop KO genetic rescue; serum antibody measurement","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models (KO, conditional KO, genetic rescue), mechanistic pathway (PANX3→ATP→P2RX4→ER homeostasis), replicated across in vitro and in vivo systems","pmids":["38355795"],"is_preprint":false},{"year":2020,"finding":"Increased surface density of P2X4 receptors (achieved via internalization-defective P2X4mCherryIN knock-in) alters hippocampal LTP and LTD at CA1 synapses without affecting basal excitatory transmission, and produces anxiolytic effects and spatial memory deficits in mice.","method":"Conditional knock-in mice (Floxed P2X4mCherryIN); electrophysiology (LTP/LTD at CA1 synapses); behavioral tests (anxiety, spatial memory)","journal":"Molecular psychiatry","confidence":"High","confidence_rationale":"Tier 2 / Strong — purpose-built genetic model preventing constitutive endocytosis with direct electrophysiology and behavioral phenotyping","pmids":["31911635"],"is_preprint":false},{"year":2020,"finding":"P2X4R activation in renal proximal tubular cells drives NLRP3 inflammasome signaling (NLRP3 and caspase-1 induction, IL-1β processing); P2X4 KO mice showed significantly attenuated NLRP3 inflammasome activation after renal ischemia-reperfusion, and P2X4 agonist ivermectin induced NLRP3 inflammasome activation in human proximal tubule cells.","method":"P2X4 KO mice; ischemia-reperfusion model; ATPγS stimulation of isolated renal proximal tubules; 5-BDBD inhibitor; western blot for NLRP3, caspase-1, IL-1β; ivermectin stimulation of human proximal tubule cells","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO in in vivo and ex vivo contexts plus pharmacological activation/inhibition with multiple mechanistic readouts","pmids":["32086866"],"is_preprint":false},{"year":2022,"finding":"Chemotherapy-induced tumor cell death releases ATP that activates P2X4 in neighboring colorectal cancer cells, triggering mTOR-dependent pro-survival signaling via elevated reactive oxygen species and increased DNA damage; P2X4 inhibition or mTOR blockade synergizes with chemotherapy to cause massive ROS-dependent cancer cell death.","method":"Patient-derived colorectal tumor organoids; ATP release measurement; P2X4 receptor inhibition; mTOR pathway (S6 phosphorylation) assay; ROS scavenging; combination chemotherapy experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic pathway (dying cell ATP → P2X4 → ROS → DNA damage → mTOR addiction) established in clinically relevant patient-derived organoids with multiple pharmacological interventions","pmids":["36385525"],"is_preprint":false},{"year":2023,"finding":"Cryo-EM structures of zebrafish P2X4 in complex with allosteric antagonists BX430 and BAY-1797 reveal both bind the same allosteric site at subunit interfaces at the top of the extracellular domain; structure-based mutagenesis identified critical residues for allosteric inhibition of both zebrafish and human P2X4. The binding stabilizes a conformation that prevents structural changes of the extracellular domain associated with channel activation.","method":"Cryo-EM structure determination; structure-based mutagenesis; electrophysiology validation of mutant effects","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structures with mutagenesis and functional electrophysiological validation","pmids":["37833294"],"is_preprint":false},{"year":2014,"finding":"Allosteric modulator ivermectin (IVM) increases efficacy of ATP, slows receptor deactivation and desensitization, and specifically enables transition from open to dilated pore state of rat P2X4R; mutagenesis of vestibular and transmembrane domain residues showed IVM has distinct effects on channel opening versus pore dilation, with pore dilation coupled to receptor re-sensitization that rescues receptors from desensitization.","method":"Whole-cell patch clamp of rat P2X4R in HEK293T cells; ivermectin treatment; vestibular and TM domain mutagenesis; Markov state kinetic modeling","journal":"Pflugers Archiv","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — electrophysiology with site-directed mutagenesis and kinetic modeling in a single lab","pmids":["24917516"],"is_preprint":false},{"year":2016,"finding":"P2X4 receptor on vascular endothelial cells is required for ischemic preconditioning-mediated neuroprotection; fluid shear stress (mimicking reperfusion) stimulates P2X4, which promotes increased expression of the neuroprotective molecule osteopontin; intracerebroventricular administration of osteopontin recapitulated the neuroprotective effect.","method":"P2X4 knockout mice; MCAO model; fluid shear stress stimulation; osteopontin expression measurement; ICV administration of osteopontin","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus fluid shear stress experiment plus osteopontin rescue, single lab","pmids":["27173846"],"is_preprint":false},{"year":2021,"finding":"HCV infection activates a caspase-3/pannexin-1/P2X4 pathway that controls secretion of exosomes and exosomal miRNAs (miR-122, miR-146a) from infected hepatocytes; inhibition of caspase-3, Panx1, or P2X4 each decreased exosome and exosomal miRNA secretion.","method":"Inhibition of caspase-3, pannexin-1, and P2X4 in HCV-infected Huh7.5.1 cells; exosome isolation and miRNA quantification","journal":"Hepatology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — pharmacological inhibition of each pathway component with consistent functional readout, single lab","pmids":["34218459"],"is_preprint":false},{"year":2020,"finding":"P2X4 and P2X7 channels promote initial Ca2+ microdomains tens of milliseconds after T cell stimulation; pannexin-1-dependent activation of P2X4 occurs in the absence of TCR/CD3 stimulation, and upon TCR stimulation ATP release autocrinally activates both P2X4 and P2X7 to amplify Ca2+ microdomains within the first second of T cell activation.","method":"High-resolution Ca2+ live-cell imaging; P2rx4 and P2rx7 knockout T cells; pharmacological inhibition/blocking of P2X4 and P2X7; pannexin-1 dependence assessed","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO mice combined with pharmacological inhibition and high-resolution millisecond-scale Ca2+ imaging","pmids":["35119925"],"is_preprint":false},{"year":2023,"finding":"Microglial P2X4 upregulation (increased surface P2X4 in reactive microglia) is required for tactile allodynia and spinal neuron hyperexcitability in neuropathic pain in both male and female mice; global and myeloid-specific P2X4 KO mice both lack these responses, and pharmacological blockade of P2X4 or TrkB relieves tactile allodynia.","method":"P2X4mCherryIN knock-in mice; global P2X4KO; myeloid-specific P2X4KO; nerve injury neuropathy model; in vivo electrophysiology; von Frey testing; TrkB pharmacological blockade","journal":"iScience","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models (global KO, myeloid-specific KO, KI) plus pharmacology establishing myeloid P2X4 as necessary for pain circuitry","pmids":["37860691"],"is_preprint":false},{"year":2012,"finding":"P2X4 knockdown in RAW264.7 macrophages reduces the initial peak of intracellular Ca2+ after ATP treatment but does not affect P2X7-mediated pore formation or ERK1/2 and p38 MAPK activation; however, P2X4 knockdown significantly suppresses P2X7-dependent macrophage cell death, indicating P2X4 contributes to P2X7-mediated cell death via Ca2+ influx but not pore formation or MAPK signaling.","method":"shRNA knockdown of P2X4; Ca2+ imaging; large pore formation assay; ERK1/2 and p38 MAPK phosphorylation western blot; cell viability assay with ATP and BzATP","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — shRNA KD with multiple pathway readouts dissecting P2X4 contribution from P2X7, single lab","pmids":["22349510"],"is_preprint":false},{"year":1998,"finding":"Full-length human P2X4 cDNA encodes a 388-residue protein; injection of full-length but not alternatively spliced cRNA into Xenopus oocytes produces ATP-gated non-selective cation currents, establishing that the alternatively spliced variant (whose first 90 aa are replaced by an hsp-90 homologous sequence) is non-functional as an ion channel.","method":"Xenopus oocyte expression; cRNA injection; electrophysiology; in vitro translation; Northern blot; RT-PCR; RNase protection assay","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Xenopus expression with direct electrophysiology for functional validation, single lab","pmids":["9511769"],"is_preprint":false},{"year":2022,"finding":"P2X4 is primarily localized in endolysosomes of breast cancer cells and promotes cancer progression by regulating lysosome acidity, promoting autophagy and cell survival, and driving epithelial-to-mesenchymal transition (EMT); pharmacological and siRNA-mediated inhibition of P2X4 both inhibited autophagy and EMT, and rescue of P2X4 in knocked-down cells restored the aggressive phenotype.","method":"P2X4 siRNA knockdown; pharmacological inhibition; rescue experiment; lysosome acidity measurement; autophagy assays; EMT marker expression; in vivo mouse mammary tumor model","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KD plus rescue plus in vivo model with mechanistic readouts (lysosome acidity, autophagy, EMT), single lab","pmids":["35411034"],"is_preprint":false},{"year":2021,"finding":"Sarcoma patient-derived extracellular vesicle proteins (including Del-1 and SDF-1) trigger trafficking of lysosomal P2XR4 to the cell membrane of endothelial cells, required for cell motility and formation of stable vascular networks; P2XR4 blockade reduced EV-induced vessel formation in angioreactors and intratumor vascularization in mouse xenografts.","method":"Proteomics of plasma EVs; Ca2+ mobilization assay; mitochondrial activation assay; P2XR4 surface translocation imaging; P2XR4 antagonist treatment; in vitro angiogenesis and Transwell assays; mouse xenograft angioreactor model","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic pathway linking EV cargo→P2XR4 lysosome-to-membrane translocation→angiogenesis, in vitro and in vivo, single lab","pmids":["34404763"],"is_preprint":false},{"year":2012,"finding":"P2X4 inhibition (pharmacological blockade) reduced microglial membrane ruffling, TNFα secretion, and morphological changes in LPS-activated microglia in vitro, and prevented LPS-induced microglial cell death in vivo, whereas P2X4 facilitation potentiated LPS-induced microglial loss; P2X4 activity thus controls the fate and survival of activated microglia.","method":"Patch-clamp recordings of LPS-activated microglia; P2X4 blockade/facilitation in vitro and in vivo (LPS injection); TNFα ELISA; morphology and survival analysis","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — electrophysiology plus pharmacological gain/loss of function with cellular outcome readouts, single lab","pmids":["24254916"],"is_preprint":false}],"current_model":"P2X4 (P2RX4) is an ATP-gated, trimeric, non-selective cation channel highly permeable to Ca2+, predominantly localized to late endosomes and lysosomes via N-terminal di-leucine and C-terminal tyrosine-based trafficking motifs; N-linked glycosylation is required for its surface expression and detergent solubility. Upon lysosomal exocytosis (triggered by phagocytosis, CCL2/CCR2 signaling, or changes in lysosomal pH), P2X4 traffics to the plasma membrane where extracellular ATP activates it, causing Ca2+ influx that feeds into multiple downstream pathways including PI3K/Akt-dependent microglial chemotaxis, BDNF release from sensory neurons, TRPM6 inhibition, CaM-dependent endolysosomal membrane fusion, NLRP3 inflammasome activation, and mitochondrial ATP synthesis feed-forward loops in T cells. P2X4 also forms heteromeric channels with P2X6 and P2X1 subunits (generating novel pharmacological phenotypes) and physically associates with P2X7 (potentiating P2X7-dependent cell death), while its pore can dilate to allow passage of large organic molecules in a phosphoinositide-regulated, pannexin-independent manner. In bone marrow, P2RX4 senses PANX3-released ATP from osteoblasts to support plasma cell survival via regulation of ER homeostasis, and in the tumor microenvironment P2X4 transduces dying-cell ATP signals to activate mTOR-dependent pro-survival programs in neighboring cancer cells."},"narrative":{"mechanistic_narrative":"P2X4 (P2RX4) is an ATP-gated, non-selective cation channel that functions as a Ca2+ entry pathway controlling diverse processes including immune cell migration, inflammation, neuronal sensitization, and cell survival [PMID:17299767, PMID:29894310, PMID:29343707]. The functional channel is a trimer assembled from a 388-residue subunit, and only the full-length, N-linked glycosylated form reaches the plasma membrane while the non-glycosylated species remains intracellular and detergent-insoluble [PMID:9511769, PMID:11864978]. P2X4 is predominantly stored in lysosomal/endolysosomal compartments, directed there by N-terminal di-leucine-like and C-terminal tyrosine-based trafficking motifs, and its surface availability is gated by regulated lysosomal exocytosis triggered by stimuli such as phagocytosis, chloroquine, CCL2/CCR2 signaling, or extracellular-vesicle cargo [PMID:24935743, PMID:19283779, PMID:22222817, PMID:34404763]. Once at the surface, ATP-gated Ca2+ influx through P2X4 drives downstream programs: PI3K/Akt-dependent microglial chemotaxis [PMID:17299767], BDNF-dependent spinal sensitization in sensory neurons during inflammatory and neuropathic pain [PMID:29343707, PMID:37860691], NLRP3 inflammasome activation [PMID:32086866], and a mitochondria-coupled feed-forward Ca2+/ATP loop sustaining T-cell polarization and migration [PMID:29894310, PMID:35119925]. At endolysosomal membranes the channel forms a Ca2+-dependent complex with calmodulin to promote membrane fusion and vacuolation [PMID:26101220]. P2X4 assembles into heteromeric channels with P2X6 and P2X1 subunits, each conferring distinct pharmacology [PMID:9736638, PMID:15686495], and physically associates with P2X7 in an ATP-driven manner that potentiates P2X7-mediated pore formation, IL-1β release, and cell death through P2X4-supplied Ca2+ influx [PMID:17785580, PMID:26456657, PMID:22349510]. Prolonged activation drives a non-cytolytic, phosphoinositide-regulated, pannexin-independent pore dilation permeable to large organic cations [PMID:22318986]. The channel is allosterically potentiated by ivermectin, which slows desensitization and enables pore dilation [PMID:24917516], and inhibited by selective allosteric antagonists such as BX430; cryo-EM defines a shared allosteric antagonist site at extracellular subunit interfaces that locks the channel against activation [PMID:25597706, PMID:37833294]. In disease contexts P2X4 senses osteoblast PANX3-released ATP to maintain bone-marrow plasma cell survival via ER homeostasis [PMID:38355795] and transduces dying-cell ATP into mTOR-dependent pro-survival, ROS-driven programs in colorectal cancer [PMID:36385525].","teleology":[{"year":1998,"claim":"Establishing the molecular identity of human P2X4 and which transcript is functional defined the channel-forming unit and showed that an alternatively spliced variant cannot form a channel.","evidence":"Xenopus oocyte cRNA expression with electrophysiology and transcript mapping of full-length vs. spliced human P2X4","pmids":["9511769"],"confidence":"Medium","gaps":["Did not define subunit stoichiometry","No structural information on the channel"]},{"year":1998,"claim":"Demonstrating co-assembly of P2X4 with P2X6 established that P2X4 forms heteromeric channels with novel pharmacology rather than acting only as a homomer.","evidence":"Co-purification of epitope-tagged subunits from HEK-293 cells plus two-electrode voltage-clamp in oocytes","pmids":["9736638"],"confidence":"High","gaps":["Native tissue contribution of P2X4/P2X6 heteromers not established","Stoichiometry within the heteromer not resolved"]},{"year":2002,"claim":"Identifying N-linked glycosylation as a requirement for surface expression explained how the channel is gated at the level of trafficking and showed a cardiac inotropic function.","evidence":"Tunicamycin glycosylation block, surface biotinylation, antisense knockdown and Ca2+/contractility assays in cardiac myocytes","pmids":["11864978"],"confidence":"High","gaps":["Specific glycosylation sites not mapped here","Did not address lysosomal retention motifs"]},{"year":2005,"claim":"Showing P2X1+P2X4 form trimeric heteromers extended the subunit-combination repertoire and revealed mixed kinetic/pharmacological phenotypes.","evidence":"His-tag affinity co-purification with BN-PAGE size confirmation and oocyte electrophysiology","pmids":["15686495"],"confidence":"High","gaps":["In vivo relevance of P2X1/P2X4 heteromers unknown","Tissue distribution of the heteromer not defined"]},{"year":2007,"claim":"Linking P2X4 Ca2+ influx to PI3K/Akt downstream of P2Y12 defined a mechanistic role in ATP-induced microglial chemotaxis.","evidence":"Dunn chamber chemotaxis, PI3K inhibitors, Akt phosphorylation readout, and lentiviral shRNA knockdown","pmids":["17299767"],"confidence":"High","gaps":["Did not establish how P2X4 reaches the surface during chemotaxis","Connection to lysosomal trafficking not yet made"]},{"year":2007,"claim":"Demonstrating physical P2X4–P2X7 association that increases P2X4 surface fraction and shapes P2X7 currents framed P2X4 as a modulator of P2X7 signaling.","evidence":"Reciprocal Co-IP from HEK293 cells and macrophages, surface biotinylation, dominant-negative mutagenesis and patch clamp","pmids":["17785580"],"confidence":"High","gaps":["Whether a stable heteromeric channel forms vs. functional crosstalk was not fully resolved","Stoichiometry of the association unknown"]},{"year":2009,"claim":"Showing lysosomal storage of P2X4 and stimulus-triggered surface delivery revealed that functional channel availability is controlled post-translationally by exocytosis, not total expression.","evidence":"Surface biotinylation, patch clamp and pharmacological lysosomal secretion (phagocytosis, chloroquine) in alveolar macrophages","pmids":["19283779"],"confidence":"High","gaps":["Trafficking motifs responsible not yet identified","Molecular machinery of the exocytic step undefined"]},{"year":2012,"claim":"A cluster of studies defined how surface P2X4 is dynamically regulated: CCL2/CCR2-driven lysosomal exocytosis delivers it to the membrane, ATP-induced Ca2+ and p38 MAPK control its lateral mobility, and prolonged activation drives phosphoinositide-dependent, pannexin-independent pore dilation.","evidence":"Surface biotinylation, GFP-P2X4 live imaging and β-hexosaminidase release; quantum-dot single-molecule tracking; dye-uptake/patch clamp with carbenoxolone and wortmannin in microglia","pmids":["22222817","22393055","22318986"],"confidence":"High","gaps":["Molecular identity of the dilated permeation pathway not structurally defined","p38 MAPK target on P2X4 not identified"]},{"year":2012,"claim":"Dissecting P2X4 contribution to P2X7 outcomes showed P2X4-supplied Ca2+ influx is required for P2X7-dependent macrophage death but not for pore formation or MAPK signaling.","evidence":"shRNA knockdown with Ca2+ imaging, pore assays, MAPK westerns and viability in RAW264.7 macrophages","pmids":["22349510"],"confidence":"Medium","gaps":["Single cell line, single lab","Did not resolve whether effect requires physical P2X4–P2X7 complex"]},{"year":2014,"claim":"Identifying N-terminal di-leucine and C-terminal tyrosine trafficking motifs and validating a pHluorin reporter explained the molecular basis of lysosomal targeting and clarified that ivermectin acts allosterically rather than by surface delivery.","evidence":"P2X4-pHluorin live imaging across multiple cell types with ivermectin treatment; complementary patch-clamp/mutagenesis kinetic modeling of ivermectin action","pmids":["24935743","24917516"],"confidence":"High","gaps":["Adaptor proteins reading the motifs not identified","Coupling between pore dilation and re-sensitization mechanistically incomplete"]},{"year":2014,"claim":"Demonstrating activity-dependent, specific inhibition of TRPM6 by P2X4 placed the channel in cation-channel crosstalk regulating Mg2+ handling.","evidence":"Whole-cell patch clamp with ATP-sensitivity mutant and TRPM7/P2X6 specificity controls","pmids":["24413910"],"confidence":"Medium","gaps":["Molecular mechanism of TRPM6 inhibition undefined (kinase-independent)","Single lab, heterologous system"]},{"year":2015,"claim":"A set of studies established P2X4 as a Ca2+ source coupling to organelle and cytoskeletal functions: endolysosomal P2X4–calmodulin complexes drive membrane fusion/vacuolation, and indirect ATP-autocrine activation underlies podocyte mechanotransduction.","evidence":"Cell-free endolysosome fusion assay, P2X4–CaM Co-IP and gene disruption; podocyte patch clamp with TRPC knockouts, 5-BDBD and ATP-release measurement","pmids":["26101220","26160898"],"confidence":"High","gaps":["How channel-localized Ca2+ is spatially restricted to fusion sites not resolved","Source of ATP for autocrine activation in podocytes not fully defined"]},{"year":2015,"claim":"Mapping the ATP-driven P2X7 C-terminal interaction with P2X4 to functional outcomes and developing the selective allosteric antagonist BX430 advanced both mechanism and pharmacology.","evidence":"Co-IP/FRET with P2X4 KO functional readouts (death, dye uptake, IL-1β); calcium/dye-uptake and electrophysiology selectivity profiling for BX430","pmids":["26456657","25597706"],"confidence":"Medium","gaps":["BX430 binding site not yet structurally defined at this stage","Stoichiometry and physiological prevalence of P2X4–P2X7 complexes unresolved"]},{"year":2016,"claim":"Identifying presynaptic P2X4 on AgRP-NPY terminals and endothelial P2X4 in ischemic preconditioning broadened the channel's roles into circuit neuromodulation and vascular neuroprotection.","evidence":"BAC reporter mice with slice electrophysiology and leptin/food-deprivation manipulation; P2X4 KO MCAO model with fluid shear stress and osteopontin rescue","pmids":["27559172","27173846"],"confidence":"Medium","gaps":["Mechanism coupling shear stress to osteopontin via P2X4 not detailed","Presynaptic trafficking control of P2X4 in neurons not defined"]},{"year":2017,"claim":"FRET evidence that P2X4 and P2X7 are in proximity but coexpression behaves as independent homomers tempered the heteromeric-channel model, favoring functional crosstalk over a dominant heteromer phenotype.","evidence":"FRET with labeled subunits and two-electrode voltage clamp pharmacology in Xenopus oocytes","pmids":["29213241"],"confidence":"Medium","gaps":["Heterologous system may not reflect native conditions","Does not reconcile with functional Ca2+/death crosstalk reported elsewhere"]},{"year":2018,"claim":"Three studies linked P2X4 Ca2+ signaling to physiological output: a mitochondria-coupled feed-forward loop sustaining T-cell migration, P2X4-upstream BDNF release driving spinal pain sensitization, and lysosomal-exocytosis-dependent fibrogenesis in hepatic myofibroblasts.","evidence":"Mitochondria/P2X4 colocalization imaging with in vivo lung transplant; P2RX4 KO mice with DRG Ca2+ imaging and spinal phospho-pathway westerns; P2X4 KO fibrosis models with calcium/exocytosis readouts","pmids":["29894310","29343707","29802948"],"confidence":"High","gaps":["How localized mitochondrial ATP feeds P2X4 spatially incomplete","Direct demonstration of P2X4-triggered BDNF exocytosis vesicle machinery lacking"]},{"year":2020,"claim":"Genetic models defined P2X4 roles in inflammasome activation, synaptic plasticity/behavior, and bone-marrow plasma cell survival, the last revealing a PANX3→ATP→P2RX4→ER homeostasis axis.","evidence":"P2X4 KO renal ischemia-reperfusion with inflammasome westerns; internalization-defective P2X4mCherryIN knock-in with LTP/LTD and behavior; Panx3/P2rx4 KO and B-lineage Chop-rescue plasma cell study","pmids":["32086866","31911635","38355795"],"confidence":"High","gaps":["How P2X4 Ca2+ couples to NLRP3 assembly not detailed","Mechanism linking P2X4 to ATF4/CHOP-controlled ER homeostasis incomplete"]},{"year":2022,"claim":"Tumor-context studies established that dying-cell ATP activates P2X4 to drive mTOR/ROS pro-survival signaling in colorectal cancer and that endolysosomal P2X4 supports breast cancer autophagy and EMT.","evidence":"Patient-derived organoids with ATP release, P2X4 inhibition, S6 phosphorylation and ROS scavenging; breast cancer siRNA/rescue with lysosome acidity, autophagy, EMT markers and xenograft","pmids":["36385525","35411034"],"confidence":"High","gaps":["Link between P2X4 Ca2+ and mTOR activation mechanistically indirect","Breast cancer study single lab/Medium confidence"]},{"year":2023,"claim":"Cryo-EM of P2X4 with BX430 and BAY-1797 defined a shared allosteric antagonist site at extracellular subunit interfaces, and genetic models established myeloid P2X4 upregulation as necessary for neuropathic tactile allodynia.","evidence":"Cryo-EM structures with structure-based mutagenesis/electrophysiology; global, myeloid-specific KO and P2X4mCherryIN knock-in nerve-injury models with in vivo electrophysiology and TrkB blockade","pmids":["37833294","37860691"],"confidence":"High","gaps":["Structures are zebrafish P2X4; full human apo/activated states not detailed here","Signal coupling microglial P2X4 to TrkB/BDNF in vivo not fully resolved"]},{"year":null,"claim":"It remains unresolved how a single lysosomally-stored channel selectively delivers Ca2+ to such divergent downstream effectors (NLRP3, mTOR, CaM-fusion, BDNF release, ER stress) in a context-specific manner, and which trafficking adaptors and spatial microdomains direct stimulus-specific surface deployment.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model of how P2X4 Ca2+ is decoded into distinct effector pathways","Adaptor proteins recognizing the di-leucine/tyrosine motifs unidentified","Native human channel structures in distinct functional states lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[3,17,31]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[12,31]}],"localization":[{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[5,9,11,32]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[11,9]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,5,6,4]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,17,23]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[22,28,30]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[5,6,11,19]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[14,30,20]}],"complexes":["P2X4/P2X6 heteromeric channel","P2X1/P2X4 heteromeric channel","P2X4–P2X7 receptor assembly","P2X4–calmodulin endolysosomal complex"],"partners":["P2RX7","P2RX6","P2RX1","CALM1","PANX3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q99571","full_name":"P2X purinoceptor 4","aliases":["ATP receptor","Purinergic receptor"],"length_aa":388,"mass_kda":43.4,"function":"ATP-gated nonselective transmembrane cation channel permeable to potassium, sodium and calcium (PubMed:9016352). CTP, but not GTP or UTP, functions as a weak affinity agonist for P2RX4 (By similarity). Activated by extracellularly released ATP, it plays multiple role in immunity and central nervous system physiology (PubMed:35165166). Plays a key role in initial steps of T-cell activation and Ca(2+) microdomain formation (By similarity). Also participates in basal T-cell activity without TCR/CD3 stimulation (By similarity). Promotes the differentiation and activation of Th17 cells via expression of retinoic acid-related orphan receptor C/RORC (PubMed:35165166). Upon activation, drives microglia motility via the PI3K/Akt pathway (By similarity). Could also function as an ATP-gated cation channel of lysosomal membranes (By similarity)","subcellular_location":"Cell membrane; Lysosome membrane","url":"https://www.uniprot.org/uniprotkb/Q99571/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/P2RX4","classification":"Not Classified","n_dependent_lines":18,"n_total_lines":1208,"dependency_fraction":0.014900662251655629},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/P2RX4","total_profiled":1310},"omim":[{"mim_id":"608422","title":"PANNEXIN 3; PANX3","url":"https://www.omim.org/entry/608422"},{"mim_id":"605552","title":"ABDOMINAL OBESITY-METABOLIC SYNDROME 1; AOMS1","url":"https://www.omim.org/entry/605552"},{"mim_id":"602566","title":"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 7; P2RX7","url":"https://www.omim.org/entry/602566"},{"mim_id":"600846","title":"PURINERGIC RECEPTOR P2X, LIGAND-GATED ION CHANNEL, 4; P2RX4","url":"https://www.omim.org/entry/600846"},{"mim_id":"172410","title":"PHOSPHOLIPASE A2, GROUP IB; PLA2G1B","url":"https://www.omim.org/entry/172410"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/P2RX4"},"hgnc":{"alias_symbol":["P2X4"],"prev_symbol":[]},"alphafold":{"accession":"Q99571","domains":[{"cath_id":"1.10.287.940","chopping":"17-54_331-367","consensus_level":"medium","plddt":90.7641,"start":17,"end":367},{"cath_id":"2.60.490.10","chopping":"58-118_167-328","consensus_level":"high","plddt":91.6772,"start":58,"end":328}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99571","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q99571-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q99571-F1-predicted_aligned_error_v6.png","plddt_mean":89.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=P2RX4","jax_strain_url":"https://www.jax.org/strain/search?query=P2RX4"},"sequence":{"accession":"Q99571","fasta_url":"https://rest.uniprot.org/uniprotkb/Q99571.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q99571/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99571"}},"corpus_meta":[{"pmid":"17299767","id":"PMC_17299767","title":"Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxis.","date":"2007","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/17299767","citation_count":253,"is_preprint":false},{"pmid":"9736638","id":"PMC_9736638","title":"Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9736638","citation_count":204,"is_preprint":false},{"pmid":"17785580","id":"PMC_17785580","title":"Evidence for functional P2X4/P2X7 heteromeric receptors.","date":"2007","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17785580","citation_count":193,"is_preprint":false},{"pmid":"29973381","id":"PMC_29973381","title":"P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis.","date":"2018","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29973381","citation_count":159,"is_preprint":false},{"pmid":"29179879","id":"PMC_29179879","title":"P2X4: A fast and sensitive purinergic receptor.","date":"2017","source":"Biomedical journal","url":"https://pubmed.ncbi.nlm.nih.gov/29179879","citation_count":137,"is_preprint":false},{"pmid":"29894310","id":"PMC_29894310","title":"Purinergic P2X4 receptors and mitochondrial ATP production regulate T cell migration.","date":"2018","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/29894310","citation_count":129,"is_preprint":false},{"pmid":"28588493","id":"PMC_28588493","title":"P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology.","date":"2017","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28588493","citation_count":121,"is_preprint":false},{"pmid":"24191146","id":"PMC_24191146","title":"P2X4 receptors and neuropathic pain.","date":"2013","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24191146","citation_count":116,"is_preprint":false},{"pmid":"26101220","id":"PMC_26101220","title":"Calcium release through P2X4 activates calmodulin to promote endolysosomal membrane fusion.","date":"2015","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/26101220","citation_count":112,"is_preprint":false},{"pmid":"23075067","id":"PMC_23075067","title":"N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists.","date":"2012","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23075067","citation_count":91,"is_preprint":false},{"pmid":"29875325","id":"PMC_29875325","title":"Macrophage P2X4 receptors augment bacterial killing and protect against sepsis.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/29875325","citation_count":90,"is_preprint":false},{"pmid":"24254916","id":"PMC_24254916","title":"P2X4 receptors control the fate and survival of activated microglia.","date":"2013","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/24254916","citation_count":83,"is_preprint":false},{"pmid":"15686495","id":"PMC_15686495","title":"Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15686495","citation_count":79,"is_preprint":false},{"pmid":"22222817","id":"PMC_22222817","title":"CCL2 promotes P2X4 receptor trafficking to the cell surface of microglia.","date":"2012","source":"Purinergic signalling","url":"https://pubmed.ncbi.nlm.nih.gov/22222817","citation_count":78,"is_preprint":false},{"pmid":"30165876","id":"PMC_30165876","title":"Microglia P2X4 receptor contributes to central sensitization following recurrent nitroglycerin stimulation.","date":"2018","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/30165876","citation_count":77,"is_preprint":false},{"pmid":"36385525","id":"PMC_36385525","title":"Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation.","date":"2022","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/36385525","citation_count":72,"is_preprint":false},{"pmid":"32289314","id":"PMC_32289314","title":"Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke.","date":"2020","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32289314","citation_count":72,"is_preprint":false},{"pmid":"19084381","id":"PMC_19084381","title":"Alteration of purinergic P2X4 and P2X7 receptor expression in rats with temporal-lobe epilepsy induced by pilocarpine.","date":"2008","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/19084381","citation_count":72,"is_preprint":false},{"pmid":"29213241","id":"PMC_29213241","title":"Interaction of Purinergic P2X4 and P2X7 Receptor Subunits.","date":"2017","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/29213241","citation_count":70,"is_preprint":false},{"pmid":"22349510","id":"PMC_22349510","title":"Involvement of P2X4 receptor in P2X7 receptor-dependent cell death of mouse macrophages.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22349510","citation_count":70,"is_preprint":false},{"pmid":"25597706","id":"PMC_25597706","title":"Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels.","date":"2015","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25597706","citation_count":69,"is_preprint":false},{"pmid":"34092198","id":"PMC_34092198","title":"Piperine promotes autophagy flux by P2RX4 activation in SNCA/α-synuclein-induced Parkinson disease model.","date":"2021","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/34092198","citation_count":68,"is_preprint":false},{"pmid":"23303206","id":"PMC_23303206","title":"A rare functional haplotype of the P2RX4 and P2RX7 genes leads to loss of innate phagocytosis and confers increased risk of age-related macular degeneration.","date":"2013","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/23303206","citation_count":66,"is_preprint":false},{"pmid":"32756482","id":"PMC_32756482","title":"Contribution of P2X4 Receptors to CNS Function and Pathophysiology.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32756482","citation_count":63,"is_preprint":false},{"pmid":"29343707","id":"PMC_29343707","title":"Sensory neuronal P2RX4 receptors controls BDNF signaling in inflammatory pain.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29343707","citation_count":60,"is_preprint":false},{"pmid":"21385174","id":"PMC_21385174","title":"P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers.","date":"2011","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21385174","citation_count":59,"is_preprint":false},{"pmid":"22528681","id":"PMC_22528681","title":"P2X4 purinoceptor signaling in chronic pain.","date":"2012","source":"Purinergic signalling","url":"https://pubmed.ncbi.nlm.nih.gov/22528681","citation_count":58,"is_preprint":false},{"pmid":"30146940","id":"PMC_30146940","title":"P2X4-receptor participates in EAAT3 regulation via BDNF-TrkB signaling in a model of trigeminal allodynia.","date":"2018","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/30146940","citation_count":57,"is_preprint":false},{"pmid":"27867013","id":"PMC_27867013","title":"Characterization of P2X4 receptor agonists and antagonists by calcium influx and radioligand binding studies.","date":"2016","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27867013","citation_count":53,"is_preprint":false},{"pmid":"19283779","id":"PMC_19283779","title":"Dynamic regulation of the P2X4 receptor in alveolar macrophages by phagocytosis and classical activation.","date":"2009","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/19283779","citation_count":53,"is_preprint":false},{"pmid":"27559172","id":"PMC_27559172","title":"P2X4 Receptor Reporter Mice: Sparse Brain Expression and Feeding-Related Presynaptic Facilitation in the Arcuate Nucleus.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27559172","citation_count":52,"is_preprint":false},{"pmid":"22318986","id":"PMC_22318986","title":"P2X4 receptor channels form large noncytolytic pores in resting and activated microglia.","date":"2012","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/22318986","citation_count":50,"is_preprint":false},{"pmid":"35119925","id":"PMC_35119925","title":"P2X4 and P2X7 are essential players in basal T cell activity and Ca2+ signaling milliseconds after T cell activation.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35119925","citation_count":50,"is_preprint":false},{"pmid":"28326637","id":"PMC_28326637","title":"Purinergic receptors P2RX4 and P2RX7 in familial multiple sclerosis.","date":"2017","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/28326637","citation_count":49,"is_preprint":false},{"pmid":"26456657","id":"PMC_26456657","title":"The P2X7/P2X4 interaction shapes the purinergic response in murine macrophages.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26456657","citation_count":49,"is_preprint":false},{"pmid":"23966951","id":"PMC_23966951","title":"The relationship between P2X4 and P2X7: a physiologically important interaction?","date":"2013","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23966951","citation_count":48,"is_preprint":false},{"pmid":"33897694","id":"PMC_33897694","title":"Structural and Functional Features of the P2X4 Receptor: An Immunological Perspective.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33897694","citation_count":47,"is_preprint":false},{"pmid":"24062058","id":"PMC_24062058","title":"Inhibition of P2X4 suppresses joint inflammation and damage in collagen-induced arthritis.","date":"2014","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/24062058","citation_count":47,"is_preprint":false},{"pmid":"30878800","id":"PMC_30878800","title":"Role of the P2X4 receptor in neuropathic pain.","date":"2019","source":"Current opinion in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30878800","citation_count":46,"is_preprint":false},{"pmid":"28943285","id":"PMC_28943285","title":"Ethanol differentially modulates P2X4 and P2X7 receptor activity and function in BV2 microglial cells.","date":"2017","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28943285","citation_count":45,"is_preprint":false},{"pmid":"25009459","id":"PMC_25009459","title":"P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders.","date":"2014","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25009459","citation_count":45,"is_preprint":false},{"pmid":"26160898","id":"PMC_26160898","title":"Podocyte Purinergic P2X4 Channels Are Mechanotransducers That Mediate Cytoskeletal Disorganization.","date":"2015","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/26160898","citation_count":45,"is_preprint":false},{"pmid":"38355795","id":"PMC_38355795","title":"Bone marrow plasma cells require P2RX4 to sense extracellular ATP.","date":"2024","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/38355795","citation_count":44,"is_preprint":false},{"pmid":"27863396","id":"PMC_27863396","title":"P2rx4 deficiency in mice alleviates allergen-induced airway inflammation.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27863396","citation_count":44,"is_preprint":false},{"pmid":"17934511","id":"PMC_17934511","title":"P2X1 and P2X4 receptor currents in mouse macrophages.","date":"2007","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17934511","citation_count":44,"is_preprint":false},{"pmid":"29077063","id":"PMC_29077063","title":"P2X4 Receptor-Dependent Ca2+ Influx in Model Human Monocytes and Macrophages.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29077063","citation_count":43,"is_preprint":false},{"pmid":"32086866","id":"PMC_32086866","title":"P2X4 receptor exacerbates ischemic AKI and induces renal proximal tubular NLRP3 inflammasome signaling.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32086866","citation_count":41,"is_preprint":false},{"pmid":"35411034","id":"PMC_35411034","title":"P2x4 receptor promotes mammary cancer progression by sustaining autophagy and associated mesenchymal transition.","date":"2022","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/35411034","citation_count":39,"is_preprint":false},{"pmid":"22393055","id":"PMC_22393055","title":"Imaging P2X4 receptor lateral mobility in microglia: regulation by calcium and p38 MAPK.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22393055","citation_count":39,"is_preprint":false},{"pmid":"11864978","id":"PMC_11864978","title":"P2X4 receptor is a glycosylated cardiac receptor mediating a positive inotropic response to ATP.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11864978","citation_count":39,"is_preprint":false},{"pmid":"31039505","id":"PMC_31039505","title":"P2X4 and lysosome fusion.","date":"2019","source":"Current opinion in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31039505","citation_count":38,"is_preprint":false},{"pmid":"31911635","id":"PMC_31911635","title":"Increased surface P2X4 receptor regulates anxiety and memory in P2X4 internalization-defective knock-in mice.","date":"2020","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/31911635","citation_count":38,"is_preprint":false},{"pmid":"32887026","id":"PMC_32887026","title":"The role of P2X4 receptors in chronic pain: A potential pharmacological target.","date":"2020","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/32887026","citation_count":38,"is_preprint":false},{"pmid":"35254644","id":"PMC_35254644","title":"P2X7/P2X4 Receptors Mediate Proliferation and Migration of Retinal Microglia in Experimental Glaucoma in Mice.","date":"2022","source":"Neuroscience bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/35254644","citation_count":38,"is_preprint":false},{"pmid":"27173846","id":"PMC_27173846","title":"The P2X4 receptor is required for neuroprotection via ischemic preconditioning.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27173846","citation_count":38,"is_preprint":false},{"pmid":"31015145","id":"PMC_31015145","title":"Targeting P2X4 and P2X7 receptors in multiple sclerosis.","date":"2019","source":"Current opinion in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31015145","citation_count":37,"is_preprint":false},{"pmid":"24187541","id":"PMC_24187541","title":"Effect of P2X4 and P2X7 receptor antagonism on the pressure diuresis relationship in rats.","date":"2013","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24187541","citation_count":37,"is_preprint":false},{"pmid":"24935743","id":"PMC_24935743","title":"Imaging P2X4 receptor subcellular distribution, trafficking, and regulation using P2X4-pHluorin.","date":"2014","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24935743","citation_count":36,"is_preprint":false},{"pmid":"25135400","id":"PMC_25135400","title":"P2X4 receptor regulates alcohol-induced responses in microglia.","date":"2014","source":"Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25135400","citation_count":36,"is_preprint":false},{"pmid":"35628550","id":"PMC_35628550","title":"The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory Target.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35628550","citation_count":35,"is_preprint":false},{"pmid":"32889635","id":"PMC_32889635","title":"Implication of Neuronal Versus Microglial P2X4 Receptors in Central Nervous System Disorders.","date":"2020","source":"Neuroscience bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/32889635","citation_count":34,"is_preprint":false},{"pmid":"9511769","id":"PMC_9511769","title":"The human P2X4 receptor gene is alternatively spliced.","date":"1998","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9511769","citation_count":34,"is_preprint":false},{"pmid":"15223238","id":"PMC_15223238","title":"Expression of P2X4 receptor in rat C6 glioma by tumor-associated macrophages and activated microglia.","date":"2004","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/15223238","citation_count":34,"is_preprint":false},{"pmid":"32407956","id":"PMC_32407956","title":"The role of P2X4 receptor in neuropathic pain and its pharmacological properties.","date":"2020","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/32407956","citation_count":33,"is_preprint":false},{"pmid":"34652816","id":"PMC_34652816","title":"P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer.","date":"2021","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34652816","citation_count":33,"is_preprint":false},{"pmid":"37833294","id":"PMC_37833294","title":"Structural insights into the allosteric inhibition of P2X4 receptors.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37833294","citation_count":33,"is_preprint":false},{"pmid":"30921560","id":"PMC_30921560","title":"P2X4 receptors, immunity, and sepsis.","date":"2019","source":"Current opinion in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30921560","citation_count":32,"is_preprint":false},{"pmid":"24486458","id":"PMC_24486458","title":"P2X4 receptors expressed on microglial cells in post-ischemic inflammation of brain ischemic injury.","date":"2014","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/24486458","citation_count":32,"is_preprint":false},{"pmid":"24411477","id":"PMC_24411477","title":"Carbamazepine derivatives with P2X4 receptor-blocking activity.","date":"2013","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24411477","citation_count":30,"is_preprint":false},{"pmid":"33233569","id":"PMC_33233569","title":"Inhibiting the P2X4 Receptor Suppresses Prostate Cancer Growth In Vitro and In Vivo, Suggesting a Potential Clinical Target.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33233569","citation_count":30,"is_preprint":false},{"pmid":"22785548","id":"PMC_22785548","title":"Expression of P2X₁ and P2X₄ receptors in rat trigeminal ganglion neurons.","date":"2012","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/22785548","citation_count":29,"is_preprint":false},{"pmid":"24413910","id":"PMC_24413910","title":"P2X4 receptor regulation of transient receptor potential melastatin type 6 (TRPM6) Mg2+ channels.","date":"2014","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24413910","citation_count":29,"is_preprint":false},{"pmid":"36088500","id":"PMC_36088500","title":"Pinocembrin Inhibits P2X4 Receptor-Mediated Pyroptosis in Hippocampus to Alleviate the Behaviours of Chronic Pain and Depression Comorbidity in Rats.","date":"2022","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/36088500","citation_count":29,"is_preprint":false},{"pmid":"32358018","id":"PMC_32358018","title":"Extracellular ATP Augments Antigen-Induced Murine Mast Cell Degranulation and Allergic Responses via P2X4 Receptor Activation.","date":"2020","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/32358018","citation_count":29,"is_preprint":false},{"pmid":"30545933","id":"PMC_30545933","title":"Ginsenosides Act As Positive Modulators of P2X4 Receptors.","date":"2018","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30545933","citation_count":28,"is_preprint":false},{"pmid":"34404763","id":"PMC_34404763","title":"Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34404763","citation_count":27,"is_preprint":false},{"pmid":"29802948","id":"PMC_29802948","title":"The P2X4 purinergic receptor regulates hepatic myofibroblast activation during liver fibrogenesis.","date":"2018","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/29802948","citation_count":27,"is_preprint":false},{"pmid":"33284579","id":"PMC_33284579","title":"Contribution of the P2X4 Receptor in Rat Hippocampus to the Comorbidity of Chronic Pain and Depression.","date":"2020","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33284579","citation_count":27,"is_preprint":false},{"pmid":"33187309","id":"PMC_33187309","title":"Dissection of P2X4 and P2X7 Receptor Current Components in BV-2 Microglia.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33187309","citation_count":26,"is_preprint":false},{"pmid":"31859818","id":"PMC_31859818","title":"Dexmedetomidine attenuates P2X4 and NLRP3 expression in the spine of rats with diabetic neuropathic pain.","date":"2019","source":"Acta cirurgica brasileira","url":"https://pubmed.ncbi.nlm.nih.gov/31859818","citation_count":26,"is_preprint":false},{"pmid":"34218459","id":"PMC_34218459","title":"The Pannexin 1/Purinergic Receptor P2X4 Pathway Controls the Secretion of MicroRNA-Containing Exosomes by HCV-Infected Hepatocytes.","date":"2021","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/34218459","citation_count":25,"is_preprint":false},{"pmid":"21402096","id":"PMC_21402096","title":"Pharmacologically targeting the P2rx4 gene on maintenance and reinstatement of alcohol self-administration in rats.","date":"2011","source":"Pharmacology, biochemistry, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/21402096","citation_count":24,"is_preprint":false},{"pmid":"24997270","id":"PMC_24997270","title":"Immunolocalization of the P2X4 receptor on neurons and glia in the mammalian retina.","date":"2014","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24997270","citation_count":24,"is_preprint":false},{"pmid":"20050186","id":"PMC_20050186","title":"P2X2, P2X4 and P2Y1 receptors elevate intracellular Ca2+ in mouse embryonic stem cell-derived GABAergic neurons.","date":"2009","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20050186","citation_count":24,"is_preprint":false},{"pmid":"26334550","id":"PMC_26334550","title":"Involvement of Purinergic P2X4 Receptors in Alcohol Intake of High-Alcohol-Drinking (HAD) Rats.","date":"2015","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/26334550","citation_count":23,"is_preprint":false},{"pmid":"24917516","id":"PMC_24917516","title":"Allosteric regulation of the P2X4 receptor channel pore dilation.","date":"2014","source":"Pflugers Archiv : European journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24917516","citation_count":22,"is_preprint":false},{"pmid":"15006691","id":"PMC_15006691","title":"Enhanced expression of the P2X4 receptor in Duchenne muscular dystrophy correlates with macrophage invasion.","date":"2004","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/15006691","citation_count":22,"is_preprint":false},{"pmid":"31396053","id":"PMC_31396053","title":"Dopamine Receptor Blockade Attenuates Purinergic P2X4 Receptor-Mediated Prepulse Inhibition Deficits and Underlying Molecular Mechanisms.","date":"2019","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31396053","citation_count":22,"is_preprint":false},{"pmid":"37860691","id":"PMC_37860691","title":"Microglial P2X4 receptors are essential for spinal neurons hyperexcitability and tactile allodynia in male and female neuropathic mice.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/37860691","citation_count":22,"is_preprint":false},{"pmid":"33907041","id":"PMC_33907041","title":"P2X4 receptor participates in autophagy regulation in Parkinson's disease.","date":"2021","source":"Neural regeneration research","url":"https://pubmed.ncbi.nlm.nih.gov/33907041","citation_count":21,"is_preprint":false},{"pmid":"24574541","id":"PMC_24574541","title":"Exaggerated renal fibrosis in P2X4 receptor-deficient mice following unilateral ureteric obstruction.","date":"2014","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/24574541","citation_count":21,"is_preprint":false},{"pmid":"24145861","id":"PMC_24145861","title":"P2X4 promotes interleukin‑1β production in osteoarthritis via NLRP1.","date":"2013","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/24145861","citation_count":21,"is_preprint":false},{"pmid":"35153623","id":"PMC_35153623","title":"Role of P2X4/NLRP3 Pathway-Mediated Neuroinflammation in Perioperative Neurocognitive Disorders.","date":"2022","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/35153623","citation_count":20,"is_preprint":false},{"pmid":"32805257","id":"PMC_32805257","title":"Functional expression of P2X1, P2X4 and P2X7 purinergic receptors in human monocyte-derived macrophages.","date":"2020","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32805257","citation_count":20,"is_preprint":false},{"pmid":"35352488","id":"PMC_35352488","title":"Activation of P2X4 receptor exacerbates acute brain injury after intracerebral hemorrhage.","date":"2022","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/35352488","citation_count":20,"is_preprint":false},{"pmid":"21107680","id":"PMC_21107680","title":"Structural insights into the function of P2X4: an ATP-gated cation channel of neuroendocrine cells.","date":"2010","source":"Cellular and molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/21107680","citation_count":20,"is_preprint":false},{"pmid":"33202978","id":"PMC_33202978","title":"P2Y2 and P2X4 Receptors Mediate Ca2+ Mobilization in DH82 Canine Macrophage Cells.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33202978","citation_count":19,"is_preprint":false},{"pmid":"33199725","id":"PMC_33199725","title":"Deviant reporter expression and P2X4 passenger gene overexpression in the soluble EGFP BAC transgenic P2X7 reporter mouse model.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33199725","citation_count":19,"is_preprint":false},{"pmid":"22222818","id":"PMC_22222818","title":"Fluvastatin suppresses native and recombinant human P2X4 receptor function.","date":"2012","source":"Purinergic signalling","url":"https://pubmed.ncbi.nlm.nih.gov/22222818","citation_count":18,"is_preprint":false},{"pmid":"34973190","id":"PMC_34973190","title":"The mechanism by which ATP regulates alcoholic steatohepatitis through P2X4 and CD39.","date":"2021","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34973190","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51820,"output_tokens":9625,"usd":0.149918,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19829,"output_tokens":6648,"usd":0.132672,"stage2_stop_reason":"end_turn"},"total_usd":0.28259,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"P2X4 and P2X6 subunits co-assemble into heteromeric ATP-gated channels with a novel pharmacological phenotype (sensitive to alpha,beta-methylene ATP, blocked by suramin and Reactive Blue 2), distinct from homomeric P2X4; assembly shown by co-purification from HEK-293 cells with epitope-tagged constructs and functional characterization in Xenopus oocytes.\",\n      \"method\": \"Co-purification/pulldown from HEK-293 cells with epitope-tagged subunits; two-electrode voltage-clamp in Xenopus oocytes\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — biochemical co-purification combined with functional electrophysiology in heterologous expression system, demonstrating novel pharmacological phenotype\",\n      \"pmids\": [\"9736638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"P2X4 receptor is N-linked glycosylated; only the glycosylated 58-kDa form is expressed on the cell surface (non-glycosylated 44-kDa form is detergent-insoluble and intracellular), establishing that N-linked glycosylation is required for plasma membrane localization and detergent solubility. P2X4 mediates the positive inotropic effect of ATP in cardiac myocytes.\",\n      \"method\": \"Tunicamycin treatment to block glycosylation; cell-surface biotinylation with streptavidin pulldown; antisense oligonucleotide knockdown; 45Ca influx assay; contractile amplitude measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal methods (glycosylation inhibition, surface biotinylation, antisense KD, calcium influx, contractility) in a single study\",\n      \"pmids\": [\"11864978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"P2X1 and P2X4 subunits form heteromeric trimeric receptors; co-purification with hexahistidyl-tagged P2X1 and BN-PAGE confirmed trimeric complexes containing both subunits. Heteromeric P2X1+4 receptors have kinetics resembling homomeric P2X4 but pharmacology (alpha,beta-methylene ATP sensitivity, suramin/TNP-ATP antagonism) resembling homomeric P2X1.\",\n      \"method\": \"Affinity co-purification with His-tagged P2X1; BN-PAGE; two-electrode voltage-clamp in Xenopus oocytes\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — biochemical co-purification with size confirmation by BN-PAGE plus functional electrophysiology\",\n      \"pmids\": [\"15686495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"P2X4 receptor is required for ATP-induced microglial chemotaxis; pharmacological blockade and lentiviral shRNA knockdown of P2X4R both significantly suppressed microglial chemotaxis. P2X4R affects the PI3K/Akt pathway downstream of P2Y12R by contributing calcium influx, since chelating extracellular calcium reduced Akt phosphorylation.\",\n      \"method\": \"Dunn chemotaxis chamber; PI3K inhibitors (wortmannin, LY294002); Akt phosphorylation assay; lentiviral shRNA knockdown; various P2X4R antagonists\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — pharmacological blockade with multiple antagonists corroborated by RNAi knockdown, with mechanistic pathway (PI3K/Akt) established\",\n      \"pmids\": [\"17299767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"P2X4 and P2X7 physically associate to form heteromeric receptors: co-immunoprecipitated from HEK293 cells and from bone marrow-derived macrophages. P2X7 increases cell-surface fraction of P2X4 two-fold. A dominant-negative P2X4 mutant (C353W) inhibits P2X7-mediated currents >2-fold, and P2X4S341W co-expressed with P2X7 confers ivermectin potentiation and TNP-ATP sensitivity absent from P2X7 alone.\",\n      \"method\": \"Co-immunoprecipitation from HEK293 cells and macrophages; cell-surface biotinylation; dominant-negative mutagenesis; whole-cell patch clamp\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reciprocal Co-IP from native cells plus mutagenesis plus electrophysiology, multiple orthogonal methods\",\n      \"pmids\": [\"17785580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"P2X4 receptors are predominantly in intracellular lysosomal compartments in alveolar macrophages; phagocytosis of zymosan or chloroquine-induced lysosomal secretion rapidly (within 4 h) increases functional surface P2X4R expression 2–7-fold without changing total protein, while classical activation (IFN-γ/TNF-α or IFN-γ/LPS) reduces surface and functional P2X4R 3-fold without altering total protein.\",\n      \"method\": \"Western blot; cell-surface biotinylation assay; whole-cell patch clamp; chloroquine treatment; phagocytosis stimulation\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (biotinylation, electrophysiology, pharmacological stimuli) demonstrating lysosomal trafficking mechanism\",\n      \"pmids\": [\"19283779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CCL2/CCR2 signaling promotes trafficking of P2X4R from lysosomal compartments to the cell surface of microglia via lysosomal exocytosis, increasing surface P2X4R without changing total cellular expression; this enhances ATP-induced Akt phosphorylation (a P2X4R-mediated response).\",\n      \"method\": \"Quantitative cell-surface biotinylation assay; time-lapse imaging of GFP-tagged P2X4R; lysosomal enzyme (β-hexosaminidase) release assay; Akt phosphorylation assay; CCR2 antagonist\",\n      \"journal\": \"Purinergic signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches (biotinylation, live imaging, lysosomal exocytosis assay, signaling readout) in a single study\",\n      \"pmids\": [\"22222817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Prolonged ATP activation of native P2X4 channels in microglia induces non-cytolytic pore dilation permeable to NMDG+ and large fluorescent dyes; this is independent of pannexin hemichannels (insensitive to carbenoxolone) and is inhibited by wortmannin (PI kinase inhibitor), indicating regulation by phosphoinositide levels.\",\n      \"method\": \"Electrophysiology (patch clamp); dye uptake assay; carbenoxolone blockade; wortmannin treatment in BV-2 and primary murine microglia\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — electrophysiology with pharmacological dissection distinguishing P2X4 from P2X7 pore-dilation mechanisms, multiple inhibitors\",\n      \"pmids\": [\"22318986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"P2X4 receptor lateral mobility in microglial processes is regulated by ATP-induced calcium influx and the p38 MAPK pathway; ATP activation increases receptor mobility, and p38 MAPK selectively regulates the slowly mobile receptor population in activated microglia.\",\n      \"method\": \"Single-molecule imaging with quantum dot-labeled P2X4 receptors; calcium chelation; p38 MAPK inhibitors; resting vs. LPS-activated microglia\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single-molecule imaging with pharmacological inhibitors, single lab\",\n      \"pmids\": [\"22393055\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"P2X4 receptor is predominantly localized to lysosomes and is targeted there by tyrosine-based and di-leucine-like trafficking motifs in its C-terminal and N-terminal regions, respectively; pHluorin imaging showed cell surface and intracellular fractions are cell-type and compartment-specific, and ivermectin does not increase the PM fraction of P2X4 but acts allosterically.\",\n      \"method\": \"pH-sensitive fluorescent P2X4-pHluorin constructs; live-cell imaging in HEK-293, hippocampal neurons, C8-B4 microglia, ATII cells; ivermectin treatment\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — purpose-built optical probe validated against WT P2X4 with multiple cell types and functional validation of allosteric mechanism\",\n      \"pmids\": [\"24935743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"P2X4 receptor activity-dependently inhibits TRPM6 Mg2+ channel activity; a P2X4 mutant with altered ATP sensitivity failed to inhibit TRPM6, and P2X4 did not inhibit the close homologue TRPM7, demonstrating specificity. Standard kinase inhibitors (PKC, PKA, PI3K) did not prevent this inhibition.\",\n      \"method\": \"Whole-cell patch clamp; P2X4 ATP-sensitivity mutant; P2X6 (non-functional) control; kinase inhibitor panel\",\n      \"journal\": \"Pflugers Archiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiology with mutagenesis and specificity controls, single lab\",\n      \"pmids\": [\"24413910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Endolysosomal P2X4 Ca2+ release is required for endolysosomal membrane fusion; P2X4 and calmodulin (CaM) form a complex at endolysosomal membranes, and P2X4 activation recruits CaM to promote fusion and vacuolation in a Ca2+-dependent manner. CaM inhibition suppressed P2X4-triggered fusion and vacuolation.\",\n      \"method\": \"P2X4 overexpression and dominant-negative mutant; cell-free endolysosome fusion assay; vacuole enlargement assay; co-immunoprecipitation of P2X4–CaM complex; CaM inhibitors; P2X4 gene disruption\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — cell-free reconstitution of fusion, co-IP of P2X4–CaM complex, dominant-negative and gene disruption, multiple orthogonal methods\",\n      \"pmids\": [\"26101220\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"P2X4 channels act as mechanotransducers in podocytes via an indirect mechanism: mechanical stimulation triggers ATP release from podocytes, which then activates P2X4 channels (TRPC6-independent), leading to increased intracellular Ca2+ and actin cytoskeleton reorganization. Mechanically induced currents were significantly decreased by P2X4 blocker 5-BDBD and were insensitive to TRPC1/3/6 knockout or broad TRPC blocker.\",\n      \"method\": \"Patch clamp of podocytes; genetic inactivation of TRPC6, TRPC1/3/6; 5-BDBD pharmacological blockade; fluorometric ATP release assay; actin cytoskeleton imaging\",\n      \"journal\": \"Journal of the American Society of Nephrology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockouts plus pharmacology plus ATP release measurement plus cytoskeletal readout, multiple orthogonal methods\",\n      \"pmids\": [\"26160898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"BX430 is a selective, non-competitive allosteric antagonist of human P2X4 with submicromolar potency (IC50 = 0.54 µM); concentration-response curves show insurmountable blockade consistent with a non-competitive allosteric mechanism. BX430 suppresses both ATP-evoked currents and ivermectin-potentiated membrane permeabilization/pore dilation.\",\n      \"method\": \"Calcium uptake assay; patch-clamp electrophysiology; fluorescent dye uptake (pore dilation); single-cell calcium imaging in THP-1–derived macrophages\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple assays (electrophysiology, calcium imaging, dye uptake) establishing allosteric mechanism with selectivity profiling across all P2X subtypes\",\n      \"pmids\": [\"25597706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"P2X7 C-terminus interacts with P2X4, and this interaction is driven by ATP; disruption of P2X4 by knockout attenuated P2X7-induced cell death, dye uptake, and IL-1β release in macrophages.\",\n      \"method\": \"Co-immunoprecipitation; FRET experiments; P2X4 knockout macrophages; functional assays (cell death, dye uptake, IL-1β ELISA)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus FRET plus KO functional readouts, single lab\",\n      \"pmids\": [\"26456657\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In the hypothalamic arcuate nucleus, P2X4 receptors are expressed presynaptically on AgRP-NPY neuron terminals (not on somata) and mediate ATP-facilitated GABA release onto POMC and paraventricular nucleus neurons; presynaptic P2X4 expression and responses are decreased by food deprivation and partially restored by leptin.\",\n      \"method\": \"BAC transgenic tdTomato reporter mice; immunohistochemistry with cell-specific GFP reporter lines; whole-cell electrophysiology in brain slices; food deprivation and leptin treatment\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — purpose-built reporter mouse crossed with cell-specific lines, combined with direct electrophysiology demonstrating presynaptic functional P2X4 activity\",\n      \"pmids\": [\"27559172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FRET analysis confirms that P2X4 and P2X7 subunits can physically interact (significant FRET signals detected between fluorophore-labeled subunits in Xenopus oocytes); however, functional electrophysiological analysis of coexpressed human P2X4 and P2X7 is consistent with independent homomers only—no novel electrophysiological phenotype attributable to heteromers was detected.\",\n      \"method\": \"FRET with EGFP/TagRFP-labeled subunits in Xenopus oocytes; two-electrode voltage clamp; selective pharmacological inhibitors\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FRET confirms proximity but functional data argues against a dominant heteromeric phenotype; single lab\",\n      \"pmids\": [\"29213241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SDF-1α triggers mitochondrial ATP production, pannexin-1-dependent ATP release, and localized co-accumulation of mitochondria with P2X4 receptors at the leading edge of T cells; autocrine P2X4 stimulation drives Ca2+ influx and sustains mitochondrial ATP synthesis required for pseudopod protrusion, T cell polarization, and migration. P2X4R antagonism blocked T cell activation and migration in vitro and prevented allograft rejection in a mouse lung transplant model.\",\n      \"method\": \"Live-cell imaging of mitochondria and P2X4 co-localization; Ca2+ imaging; P2X4 inhibition; pannexin-1 blockade; in vitro migration assays; mouse lung transplant model with P2X4 antagonist treatment\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct localization experiment tied to functional consequence (pseudopod/migration), confirmed in vivo in transplant model, multiple orthogonal methods\",\n      \"pmids\": [\"29894310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"P2RX4 expressed in sensory neurons co-localizes with BDNF and controls Ca2+ influx in DRG neurons; in P2RX4-deficient mice, BDNF-dependent signaling in the dorsal horn (Erk1/2 phosphorylation, GluN1 phosphorylation, KCC2 downregulation) triggered by peripheral inflammation is impaired, placing P2RX4 upstream of neuronal BDNF release during inflammatory pain.\",\n      \"method\": \"P2RX4 knockout mice; immunofluorescence co-localization; Ca2+ imaging in DRG neurons; western blot for phospho-Erk1/2, phospho-GluN1, KCC2 in spinal cord\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with multiple molecular pathway readouts establishing P2X4→BDNF→spinal sensitization pathway\",\n      \"pmids\": [\"29343707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"P2X4R regulates calcium entry and lysosomal exocytosis in hepatic myofibroblasts (hMFs); P2X4 genetic invalidation or pharmacological inhibition blunted hMF activation marker expression and fibrogenic properties and impacted ATP release and profibrogenic secretory profile, placing lysosomal P2X4-mediated calcium and exocytosis upstream of transcription factor activation in liver fibrogenesis.\",\n      \"method\": \"P2X4 KO mice; bile duct ligation and MCD diet models; P2X4 siRNA and pharmacological inhibition; calcium entry assays; lysosomal exocytosis measurement; hMF isolation from mouse and human liver\",\n      \"journal\": \"Journal of hepatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO in two in vivo fibrosis models, human cell validation, siRNA, and calcium/exocytosis mechanistic readouts\",\n      \"pmids\": [\"29802948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Bone marrow plasma cells use P2RX4 to sense extracellular ATP released by osteoblasts through PANX3; P2RX4 promotes plasma cell survival by regulating endoplasmic reticulum homeostasis—P2RX4 blockade causes accumulation of ER stress-associated proteins ATF4 and CHOP, and B-lineage deletion of the pro-apoptotic ATF4 target Chop prevents bone marrow plasma cell death on P2RX4 inhibition.\",\n      \"method\": \"P2rx4 and Panx3 knockout mice; in vitro osteoblast-plasma cell co-culture; 5-BDBD P2RX4-specific inhibitor; western blot for ATF4, CHOP; B-lineage-specific Chop KO genetic rescue; serum antibody measurement\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models (KO, conditional KO, genetic rescue), mechanistic pathway (PANX3→ATP→P2RX4→ER homeostasis), replicated across in vitro and in vivo systems\",\n      \"pmids\": [\"38355795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Increased surface density of P2X4 receptors (achieved via internalization-defective P2X4mCherryIN knock-in) alters hippocampal LTP and LTD at CA1 synapses without affecting basal excitatory transmission, and produces anxiolytic effects and spatial memory deficits in mice.\",\n      \"method\": \"Conditional knock-in mice (Floxed P2X4mCherryIN); electrophysiology (LTP/LTD at CA1 synapses); behavioral tests (anxiety, spatial memory)\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — purpose-built genetic model preventing constitutive endocytosis with direct electrophysiology and behavioral phenotyping\",\n      \"pmids\": [\"31911635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"P2X4R activation in renal proximal tubular cells drives NLRP3 inflammasome signaling (NLRP3 and caspase-1 induction, IL-1β processing); P2X4 KO mice showed significantly attenuated NLRP3 inflammasome activation after renal ischemia-reperfusion, and P2X4 agonist ivermectin induced NLRP3 inflammasome activation in human proximal tubule cells.\",\n      \"method\": \"P2X4 KO mice; ischemia-reperfusion model; ATPγS stimulation of isolated renal proximal tubules; 5-BDBD inhibitor; western blot for NLRP3, caspase-1, IL-1β; ivermectin stimulation of human proximal tubule cells\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO in in vivo and ex vivo contexts plus pharmacological activation/inhibition with multiple mechanistic readouts\",\n      \"pmids\": [\"32086866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Chemotherapy-induced tumor cell death releases ATP that activates P2X4 in neighboring colorectal cancer cells, triggering mTOR-dependent pro-survival signaling via elevated reactive oxygen species and increased DNA damage; P2X4 inhibition or mTOR blockade synergizes with chemotherapy to cause massive ROS-dependent cancer cell death.\",\n      \"method\": \"Patient-derived colorectal tumor organoids; ATP release measurement; P2X4 receptor inhibition; mTOR pathway (S6 phosphorylation) assay; ROS scavenging; combination chemotherapy experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic pathway (dying cell ATP → P2X4 → ROS → DNA damage → mTOR addiction) established in clinically relevant patient-derived organoids with multiple pharmacological interventions\",\n      \"pmids\": [\"36385525\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Cryo-EM structures of zebrafish P2X4 in complex with allosteric antagonists BX430 and BAY-1797 reveal both bind the same allosteric site at subunit interfaces at the top of the extracellular domain; structure-based mutagenesis identified critical residues for allosteric inhibition of both zebrafish and human P2X4. The binding stabilizes a conformation that prevents structural changes of the extracellular domain associated with channel activation.\",\n      \"method\": \"Cryo-EM structure determination; structure-based mutagenesis; electrophysiology validation of mutant effects\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structures with mutagenesis and functional electrophysiological validation\",\n      \"pmids\": [\"37833294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Allosteric modulator ivermectin (IVM) increases efficacy of ATP, slows receptor deactivation and desensitization, and specifically enables transition from open to dilated pore state of rat P2X4R; mutagenesis of vestibular and transmembrane domain residues showed IVM has distinct effects on channel opening versus pore dilation, with pore dilation coupled to receptor re-sensitization that rescues receptors from desensitization.\",\n      \"method\": \"Whole-cell patch clamp of rat P2X4R in HEK293T cells; ivermectin treatment; vestibular and TM domain mutagenesis; Markov state kinetic modeling\",\n      \"journal\": \"Pflugers Archiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — electrophysiology with site-directed mutagenesis and kinetic modeling in a single lab\",\n      \"pmids\": [\"24917516\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"P2X4 receptor on vascular endothelial cells is required for ischemic preconditioning-mediated neuroprotection; fluid shear stress (mimicking reperfusion) stimulates P2X4, which promotes increased expression of the neuroprotective molecule osteopontin; intracerebroventricular administration of osteopontin recapitulated the neuroprotective effect.\",\n      \"method\": \"P2X4 knockout mice; MCAO model; fluid shear stress stimulation; osteopontin expression measurement; ICV administration of osteopontin\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus fluid shear stress experiment plus osteopontin rescue, single lab\",\n      \"pmids\": [\"27173846\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HCV infection activates a caspase-3/pannexin-1/P2X4 pathway that controls secretion of exosomes and exosomal miRNAs (miR-122, miR-146a) from infected hepatocytes; inhibition of caspase-3, Panx1, or P2X4 each decreased exosome and exosomal miRNA secretion.\",\n      \"method\": \"Inhibition of caspase-3, pannexin-1, and P2X4 in HCV-infected Huh7.5.1 cells; exosome isolation and miRNA quantification\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — pharmacological inhibition of each pathway component with consistent functional readout, single lab\",\n      \"pmids\": [\"34218459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"P2X4 and P2X7 channels promote initial Ca2+ microdomains tens of milliseconds after T cell stimulation; pannexin-1-dependent activation of P2X4 occurs in the absence of TCR/CD3 stimulation, and upon TCR stimulation ATP release autocrinally activates both P2X4 and P2X7 to amplify Ca2+ microdomains within the first second of T cell activation.\",\n      \"method\": \"High-resolution Ca2+ live-cell imaging; P2rx4 and P2rx7 knockout T cells; pharmacological inhibition/blocking of P2X4 and P2X7; pannexin-1 dependence assessed\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO mice combined with pharmacological inhibition and high-resolution millisecond-scale Ca2+ imaging\",\n      \"pmids\": [\"35119925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Microglial P2X4 upregulation (increased surface P2X4 in reactive microglia) is required for tactile allodynia and spinal neuron hyperexcitability in neuropathic pain in both male and female mice; global and myeloid-specific P2X4 KO mice both lack these responses, and pharmacological blockade of P2X4 or TrkB relieves tactile allodynia.\",\n      \"method\": \"P2X4mCherryIN knock-in mice; global P2X4KO; myeloid-specific P2X4KO; nerve injury neuropathy model; in vivo electrophysiology; von Frey testing; TrkB pharmacological blockade\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models (global KO, myeloid-specific KO, KI) plus pharmacology establishing myeloid P2X4 as necessary for pain circuitry\",\n      \"pmids\": [\"37860691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"P2X4 knockdown in RAW264.7 macrophages reduces the initial peak of intracellular Ca2+ after ATP treatment but does not affect P2X7-mediated pore formation or ERK1/2 and p38 MAPK activation; however, P2X4 knockdown significantly suppresses P2X7-dependent macrophage cell death, indicating P2X4 contributes to P2X7-mediated cell death via Ca2+ influx but not pore formation or MAPK signaling.\",\n      \"method\": \"shRNA knockdown of P2X4; Ca2+ imaging; large pore formation assay; ERK1/2 and p38 MAPK phosphorylation western blot; cell viability assay with ATP and BzATP\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — shRNA KD with multiple pathway readouts dissecting P2X4 contribution from P2X7, single lab\",\n      \"pmids\": [\"22349510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Full-length human P2X4 cDNA encodes a 388-residue protein; injection of full-length but not alternatively spliced cRNA into Xenopus oocytes produces ATP-gated non-selective cation currents, establishing that the alternatively spliced variant (whose first 90 aa are replaced by an hsp-90 homologous sequence) is non-functional as an ion channel.\",\n      \"method\": \"Xenopus oocyte expression; cRNA injection; electrophysiology; in vitro translation; Northern blot; RT-PCR; RNase protection assay\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Xenopus expression with direct electrophysiology for functional validation, single lab\",\n      \"pmids\": [\"9511769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"P2X4 is primarily localized in endolysosomes of breast cancer cells and promotes cancer progression by regulating lysosome acidity, promoting autophagy and cell survival, and driving epithelial-to-mesenchymal transition (EMT); pharmacological and siRNA-mediated inhibition of P2X4 both inhibited autophagy and EMT, and rescue of P2X4 in knocked-down cells restored the aggressive phenotype.\",\n      \"method\": \"P2X4 siRNA knockdown; pharmacological inhibition; rescue experiment; lysosome acidity measurement; autophagy assays; EMT marker expression; in vivo mouse mammary tumor model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KD plus rescue plus in vivo model with mechanistic readouts (lysosome acidity, autophagy, EMT), single lab\",\n      \"pmids\": [\"35411034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Sarcoma patient-derived extracellular vesicle proteins (including Del-1 and SDF-1) trigger trafficking of lysosomal P2XR4 to the cell membrane of endothelial cells, required for cell motility and formation of stable vascular networks; P2XR4 blockade reduced EV-induced vessel formation in angioreactors and intratumor vascularization in mouse xenografts.\",\n      \"method\": \"Proteomics of plasma EVs; Ca2+ mobilization assay; mitochondrial activation assay; P2XR4 surface translocation imaging; P2XR4 antagonist treatment; in vitro angiogenesis and Transwell assays; mouse xenograft angioreactor model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic pathway linking EV cargo→P2XR4 lysosome-to-membrane translocation→angiogenesis, in vitro and in vivo, single lab\",\n      \"pmids\": [\"34404763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"P2X4 inhibition (pharmacological blockade) reduced microglial membrane ruffling, TNFα secretion, and morphological changes in LPS-activated microglia in vitro, and prevented LPS-induced microglial cell death in vivo, whereas P2X4 facilitation potentiated LPS-induced microglial loss; P2X4 activity thus controls the fate and survival of activated microglia.\",\n      \"method\": \"Patch-clamp recordings of LPS-activated microglia; P2X4 blockade/facilitation in vitro and in vivo (LPS injection); TNFα ELISA; morphology and survival analysis\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — electrophysiology plus pharmacological gain/loss of function with cellular outcome readouts, single lab\",\n      \"pmids\": [\"24254916\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"P2X4 (P2RX4) is an ATP-gated, trimeric, non-selective cation channel highly permeable to Ca2+, predominantly localized to late endosomes and lysosomes via N-terminal di-leucine and C-terminal tyrosine-based trafficking motifs; N-linked glycosylation is required for its surface expression and detergent solubility. Upon lysosomal exocytosis (triggered by phagocytosis, CCL2/CCR2 signaling, or changes in lysosomal pH), P2X4 traffics to the plasma membrane where extracellular ATP activates it, causing Ca2+ influx that feeds into multiple downstream pathways including PI3K/Akt-dependent microglial chemotaxis, BDNF release from sensory neurons, TRPM6 inhibition, CaM-dependent endolysosomal membrane fusion, NLRP3 inflammasome activation, and mitochondrial ATP synthesis feed-forward loops in T cells. P2X4 also forms heteromeric channels with P2X6 and P2X1 subunits (generating novel pharmacological phenotypes) and physically associates with P2X7 (potentiating P2X7-dependent cell death), while its pore can dilate to allow passage of large organic molecules in a phosphoinositide-regulated, pannexin-independent manner. In bone marrow, P2RX4 senses PANX3-released ATP from osteoblasts to support plasma cell survival via regulation of ER homeostasis, and in the tumor microenvironment P2X4 transduces dying-cell ATP signals to activate mTOR-dependent pro-survival programs in neighboring cancer cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"P2X4 (P2RX4) is an ATP-gated, non-selective cation channel that functions as a Ca2+ entry pathway controlling diverse processes including immune cell migration, inflammation, neuronal sensitization, and cell survival [#3, #17, #18]. The functional channel is a trimer assembled from a 388-residue subunit, and only the full-length, N-linked glycosylated form reaches the plasma membrane while the non-glycosylated species remains intracellular and detergent-insoluble [#31, #1]. P2X4 is predominantly stored in lysosomal/endolysosomal compartments, directed there by N-terminal di-leucine-like and C-terminal tyrosine-based trafficking motifs, and its surface availability is gated by regulated lysosomal exocytosis triggered by stimuli such as phagocytosis, chloroquine, CCL2/CCR2 signaling, or extracellular-vesicle cargo [#9, #5, #6, #33]. Once at the surface, ATP-gated Ca2+ influx through P2X4 drives downstream programs: PI3K/Akt-dependent microglial chemotaxis [#3], BDNF-dependent spinal sensitization in sensory neurons during inflammatory and neuropathic pain [#18, #29], NLRP3 inflammasome activation [#22], and a mitochondria-coupled feed-forward Ca2+/ATP loop sustaining T-cell polarization and migration [#17, #28]. At endolysosomal membranes the channel forms a Ca2+-dependent complex with calmodulin to promote membrane fusion and vacuolation [#11]. P2X4 assembles into heteromeric channels with P2X6 and P2X1 subunits, each conferring distinct pharmacology [#0, #2], and physically associates with P2X7 in an ATP-driven manner that potentiates P2X7-mediated pore formation, IL-1β release, and cell death through P2X4-supplied Ca2+ influx [#4, #14, #30]. Prolonged activation drives a non-cytolytic, phosphoinositide-regulated, pannexin-independent pore dilation permeable to large organic cations [#7]. The channel is allosterically potentiated by ivermectin, which slows desensitization and enables pore dilation [#25], and inhibited by selective allosteric antagonists such as BX430; cryo-EM defines a shared allosteric antagonist site at extracellular subunit interfaces that locks the channel against activation [#13, #24]. In disease contexts P2X4 senses osteoblast PANX3-released ATP to maintain bone-marrow plasma cell survival via ER homeostasis [#20] and transduces dying-cell ATP into mTOR-dependent pro-survival, ROS-driven programs in colorectal cancer [#23].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing the molecular identity of human P2X4 and which transcript is functional defined the channel-forming unit and showed that an alternatively spliced variant cannot form a channel.\",\n      \"evidence\": \"Xenopus oocyte cRNA expression with electrophysiology and transcript mapping of full-length vs. spliced human P2X4\",\n      \"pmids\": [\"9511769\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not define subunit stoichiometry\", \"No structural information on the channel\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating co-assembly of P2X4 with P2X6 established that P2X4 forms heteromeric channels with novel pharmacology rather than acting only as a homomer.\",\n      \"evidence\": \"Co-purification of epitope-tagged subunits from HEK-293 cells plus two-electrode voltage-clamp in oocytes\",\n      \"pmids\": [\"9736638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Native tissue contribution of P2X4/P2X6 heteromers not established\", \"Stoichiometry within the heteromer not resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identifying N-linked glycosylation as a requirement for surface expression explained how the channel is gated at the level of trafficking and showed a cardiac inotropic function.\",\n      \"evidence\": \"Tunicamycin glycosylation block, surface biotinylation, antisense knockdown and Ca2+/contractility assays in cardiac myocytes\",\n      \"pmids\": [\"11864978\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific glycosylation sites not mapped here\", \"Did not address lysosomal retention motifs\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showing P2X1+P2X4 form trimeric heteromers extended the subunit-combination repertoire and revealed mixed kinetic/pharmacological phenotypes.\",\n      \"evidence\": \"His-tag affinity co-purification with BN-PAGE size confirmation and oocyte electrophysiology\",\n      \"pmids\": [\"15686495\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of P2X1/P2X4 heteromers unknown\", \"Tissue distribution of the heteromer not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Linking P2X4 Ca2+ influx to PI3K/Akt downstream of P2Y12 defined a mechanistic role in ATP-induced microglial chemotaxis.\",\n      \"evidence\": \"Dunn chamber chemotaxis, PI3K inhibitors, Akt phosphorylation readout, and lentiviral shRNA knockdown\",\n      \"pmids\": [\"17299767\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish how P2X4 reaches the surface during chemotaxis\", \"Connection to lysosomal trafficking not yet made\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating physical P2X4–P2X7 association that increases P2X4 surface fraction and shapes P2X7 currents framed P2X4 as a modulator of P2X7 signaling.\",\n      \"evidence\": \"Reciprocal Co-IP from HEK293 cells and macrophages, surface biotinylation, dominant-negative mutagenesis and patch clamp\",\n      \"pmids\": [\"17785580\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether a stable heteromeric channel forms vs. functional crosstalk was not fully resolved\", \"Stoichiometry of the association unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showing lysosomal storage of P2X4 and stimulus-triggered surface delivery revealed that functional channel availability is controlled post-translationally by exocytosis, not total expression.\",\n      \"evidence\": \"Surface biotinylation, patch clamp and pharmacological lysosomal secretion (phagocytosis, chloroquine) in alveolar macrophages\",\n      \"pmids\": [\"19283779\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking motifs responsible not yet identified\", \"Molecular machinery of the exocytic step undefined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"A cluster of studies defined how surface P2X4 is dynamically regulated: CCL2/CCR2-driven lysosomal exocytosis delivers it to the membrane, ATP-induced Ca2+ and p38 MAPK control its lateral mobility, and prolonged activation drives phosphoinositide-dependent, pannexin-independent pore dilation.\",\n      \"evidence\": \"Surface biotinylation, GFP-P2X4 live imaging and β-hexosaminidase release; quantum-dot single-molecule tracking; dye-uptake/patch clamp with carbenoxolone and wortmannin in microglia\",\n      \"pmids\": [\"22222817\", \"22393055\", \"22318986\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular identity of the dilated permeation pathway not structurally defined\", \"p38 MAPK target on P2X4 not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Dissecting P2X4 contribution to P2X7 outcomes showed P2X4-supplied Ca2+ influx is required for P2X7-dependent macrophage death but not for pore formation or MAPK signaling.\",\n      \"evidence\": \"shRNA knockdown with Ca2+ imaging, pore assays, MAPK westerns and viability in RAW264.7 macrophages\",\n      \"pmids\": [\"22349510\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell line, single lab\", \"Did not resolve whether effect requires physical P2X4–P2X7 complex\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identifying N-terminal di-leucine and C-terminal tyrosine trafficking motifs and validating a pHluorin reporter explained the molecular basis of lysosomal targeting and clarified that ivermectin acts allosterically rather than by surface delivery.\",\n      \"evidence\": \"P2X4-pHluorin live imaging across multiple cell types with ivermectin treatment; complementary patch-clamp/mutagenesis kinetic modeling of ivermectin action\",\n      \"pmids\": [\"24935743\", \"24917516\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Adaptor proteins reading the motifs not identified\", \"Coupling between pore dilation and re-sensitization mechanistically incomplete\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating activity-dependent, specific inhibition of TRPM6 by P2X4 placed the channel in cation-channel crosstalk regulating Mg2+ handling.\",\n      \"evidence\": \"Whole-cell patch clamp with ATP-sensitivity mutant and TRPM7/P2X6 specificity controls\",\n      \"pmids\": [\"24413910\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of TRPM6 inhibition undefined (kinase-independent)\", \"Single lab, heterologous system\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A set of studies established P2X4 as a Ca2+ source coupling to organelle and cytoskeletal functions: endolysosomal P2X4–calmodulin complexes drive membrane fusion/vacuolation, and indirect ATP-autocrine activation underlies podocyte mechanotransduction.\",\n      \"evidence\": \"Cell-free endolysosome fusion assay, P2X4–CaM Co-IP and gene disruption; podocyte patch clamp with TRPC knockouts, 5-BDBD and ATP-release measurement\",\n      \"pmids\": [\"26101220\", \"26160898\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How channel-localized Ca2+ is spatially restricted to fusion sites not resolved\", \"Source of ATP for autocrine activation in podocytes not fully defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Mapping the ATP-driven P2X7 C-terminal interaction with P2X4 to functional outcomes and developing the selective allosteric antagonist BX430 advanced both mechanism and pharmacology.\",\n      \"evidence\": \"Co-IP/FRET with P2X4 KO functional readouts (death, dye uptake, IL-1β); calcium/dye-uptake and electrophysiology selectivity profiling for BX430\",\n      \"pmids\": [\"26456657\", \"25597706\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"BX430 binding site not yet structurally defined at this stage\", \"Stoichiometry and physiological prevalence of P2X4–P2X7 complexes unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identifying presynaptic P2X4 on AgRP-NPY terminals and endothelial P2X4 in ischemic preconditioning broadened the channel's roles into circuit neuromodulation and vascular neuroprotection.\",\n      \"evidence\": \"BAC reporter mice with slice electrophysiology and leptin/food-deprivation manipulation; P2X4 KO MCAO model with fluid shear stress and osteopontin rescue\",\n      \"pmids\": [\"27559172\", \"27173846\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism coupling shear stress to osteopontin via P2X4 not detailed\", \"Presynaptic trafficking control of P2X4 in neurons not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"FRET evidence that P2X4 and P2X7 are in proximity but coexpression behaves as independent homomers tempered the heteromeric-channel model, favoring functional crosstalk over a dominant heteromer phenotype.\",\n      \"evidence\": \"FRET with labeled subunits and two-electrode voltage clamp pharmacology in Xenopus oocytes\",\n      \"pmids\": [\"29213241\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Heterologous system may not reflect native conditions\", \"Does not reconcile with functional Ca2+/death crosstalk reported elsewhere\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Three studies linked P2X4 Ca2+ signaling to physiological output: a mitochondria-coupled feed-forward loop sustaining T-cell migration, P2X4-upstream BDNF release driving spinal pain sensitization, and lysosomal-exocytosis-dependent fibrogenesis in hepatic myofibroblasts.\",\n      \"evidence\": \"Mitochondria/P2X4 colocalization imaging with in vivo lung transplant; P2RX4 KO mice with DRG Ca2+ imaging and spinal phospho-pathway westerns; P2X4 KO fibrosis models with calcium/exocytosis readouts\",\n      \"pmids\": [\"29894310\", \"29343707\", \"29802948\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How localized mitochondrial ATP feeds P2X4 spatially incomplete\", \"Direct demonstration of P2X4-triggered BDNF exocytosis vesicle machinery lacking\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Genetic models defined P2X4 roles in inflammasome activation, synaptic plasticity/behavior, and bone-marrow plasma cell survival, the last revealing a PANX3→ATP→P2RX4→ER homeostasis axis.\",\n      \"evidence\": \"P2X4 KO renal ischemia-reperfusion with inflammasome westerns; internalization-defective P2X4mCherryIN knock-in with LTP/LTD and behavior; Panx3/P2rx4 KO and B-lineage Chop-rescue plasma cell study\",\n      \"pmids\": [\"32086866\", \"31911635\", \"38355795\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How P2X4 Ca2+ couples to NLRP3 assembly not detailed\", \"Mechanism linking P2X4 to ATF4/CHOP-controlled ER homeostasis incomplete\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Tumor-context studies established that dying-cell ATP activates P2X4 to drive mTOR/ROS pro-survival signaling in colorectal cancer and that endolysosomal P2X4 supports breast cancer autophagy and EMT.\",\n      \"evidence\": \"Patient-derived organoids with ATP release, P2X4 inhibition, S6 phosphorylation and ROS scavenging; breast cancer siRNA/rescue with lysosome acidity, autophagy, EMT markers and xenograft\",\n      \"pmids\": [\"36385525\", \"35411034\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Link between P2X4 Ca2+ and mTOR activation mechanistically indirect\", \"Breast cancer study single lab/Medium confidence\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Cryo-EM of P2X4 with BX430 and BAY-1797 defined a shared allosteric antagonist site at extracellular subunit interfaces, and genetic models established myeloid P2X4 upregulation as necessary for neuropathic tactile allodynia.\",\n      \"evidence\": \"Cryo-EM structures with structure-based mutagenesis/electrophysiology; global, myeloid-specific KO and P2X4mCherryIN knock-in nerve-injury models with in vivo electrophysiology and TrkB blockade\",\n      \"pmids\": [\"37833294\", \"37860691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structures are zebrafish P2X4; full human apo/activated states not detailed here\", \"Signal coupling microglial P2X4 to TrkB/BDNF in vivo not fully resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how a single lysosomally-stored channel selectively delivers Ca2+ to such divergent downstream effectors (NLRP3, mTOR, CaM-fusion, BDNF release, ER stress) in a context-specific manner, and which trafficking adaptors and spatial microdomains direct stimulus-specific surface deployment.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model of how P2X4 Ca2+ is decoded into distinct effector pathways\", \"Adaptor proteins recognizing the di-leucine/tyrosine motifs unidentified\", \"Native human channel structures in distinct functional states lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005216\", \"supporting_discovery_ids\": [31]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [3, 17, 31]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [12, 31]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [5, 9, 11, 32]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [11, 9]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 5, 6, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 17, 23]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [22, 28, 30]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [5, 6, 11, 19]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [14, 30, 20]}\n    ],\n    \"complexes\": [\n      \"P2X4/P2X6 heteromeric channel\",\n      \"P2X1/P2X4 heteromeric channel\",\n      \"P2X4–P2X7 receptor assembly\",\n      \"P2X4–calmodulin endolysosomal complex\"\n    ],\n    \"partners\": [\n      \"P2RX7\",\n      \"P2RX6\",\n      \"P2RX1\",\n      \"CALM1\",\n      \"PANX3\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}